Background  	Background  	 NNP	B-NP
Glycosaminoglycans  	Glycosaminoglycans  	 NNP	I-NP
( 	( 	 -LRB-	O
GAGs 	GAGs 	 NNP	B-NP
)  	)  	 -RRB-	O
are  	are  	 VBP	O
negatively  	negatively  	 RB	O
charged  	charged  	 VBN	O
polysaccharides  	polysaccharides  	 RB	O
derived  	derived  	 VBN	O
from  	from  	 IN	O
an  	an  	 DT	O
amino  	amino  	 JJ	B-NP
hexose 	hexose 	 NN	I-NP
.  	.  	 .	O
They  	They  	 PRP	O
are  	are  	 VBP	O
structural  	structural  	 JJ	O
and  	and  	 CC	O
functional  	functional  	 JJ	B-NP
modulators  	modulators  	 NN	I-NP
of  	of  	 IN	I-NP
extracellular  	extracellular  	 JJ	I-NP
matrices  	matrices  	 NN	I-NP
that  	that  	 WDT	O
play  	play  	 VBP	O
important  	important  	 JJ	O
roles  	roles  	 NNS	O
in  	in  	 IN	O
CNS  	CNS  	 NNP	B-NP
development  	development  	 NN	O
and  	and  	 CC	O
repair 	repair 	 NN	O
.  	.  	 .	O
They  	They  	 PRP	O
exhibit  	exhibit  	 VBD	O
both  	both  	 DT	O
stimulatory  	stimulatory  	 NN	B-NP
and  	and  	 CC	O
inhibitory  	inhibitory  	 JJ	B-NP
influences  	influences  	 NNS	I-NP
on  	on  	 IN	O
neurite  	neurite  	 JJ	B-NP
outgrowth  	outgrowth  	 NN	I-NP
and  	and  	 CC	O
survival 	survival 	 NN	O
.  	.  	 .	O
Evidence  	Evidence  	 NN	O
demonstrates  	demonstrates  	 VBZ	O
the  	the  	 DT	O
ability  	ability  	 NN	B-NP
of  	of  	 IN	I-NP
heparin  	heparin  	 JJ	I-NP
sulfates  	sulfates  	 NNS	I-NP
( 	( 	 -LRB-	O
HSs 	HSs 	 NNP	B-NP
)  	)  	 -RRB-	O
to  	to  	 TO	O
bind  	bind  	 VB	O
to  	to  	 TO	O
growth 	growth 	 NN	B-NP
/ 	/ 	 CD	I-NP
trophic  	trophic  	 CD	I-NP
factors  	factors  	 NNS	I-NP
and  	and  	 CC	O
selectively  	selectively  	 RB	O
regulate  	regulate  	 VB	O
such  	such  	 JJ	O
factors 	factors 	 NNS	O
'  	'  	 POS	O
receptors.  	receptors.  	 NNP	B-NP
[  	[  	 -LRB-	O
1  	1  	 CD	O
2  	2  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
They  	They  	 PRP	O
can  	can  	 MD	O
act  	act  	 VB	O
as  	as  	 IN	O
co-receptors  	co-receptors  	 JJ	B-NP
of  	of  	 IN	I-NP
growth 	growth 	 NN	I-NP
/ 	/ 	 CD	I-NP
trophic  	trophic  	 NNS	I-NP
and  	and  	 CC	O
survival  	survival  	 NN	B-NP
factors  	factors  	 NNS	I-NP
to  	to  	 TO	O
regulate  	regulate  	 VB	O
cell  	cell  	 NN	O
behavior  	behavior  	 NN	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
restrict  	restrict  	 VB	O
diffusion  	diffusion  	 NNS	O
and  	and  	 CC	O
create  	create  	 VB	O
a  	a  	 DT	O
relatively  	relatively  	 RB	O
high  	high  	 JJ	O
local  	local  	 JJ	O
concentration  	concentration  	 NN	B-NP
of  	of  	 IN	I-NP
ligand 	ligand 	 NN	I-NP
.  	.  	 .	O
Pigment  	Pigment  	 JJ	B-NP
epithelium-derived  	epithelium-derived  	 JJ	I-NP
factor  	factor  	 NN	I-NP
( 	( 	 -LRB-	O
PEDF 	PEDF 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
an  	an  	 DT	O
extracellular  	extracellular  	 JJ	B-NP
neuronal  	neuronal  	 JJ	I-NP
differentiation  	differentiation  	 NN	I-NP
and  	and  	 CC	O
survival  	survival  	 NN	B-NP
factor  	factor  	 NN	I-NP
for  	for  	 IN	O
cells  	cells  	 NNS	O
derived  	derived  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
retina  	retina  	 NN	B-NP
and  	and  	 CC	O
CNS 	CNS 	 NNP	B-NP
.  	.  	 .	O
It  	It  	 PRP	O
induces  	induces  	 VBZ	O
neuronal  	neuronal  	 JJ	B-NP
differentiation  	differentiation  	 NN	I-NP
in  	in  	 IN	O
retinoblastoma  	retinoblastoma  	 NN	B-NP
cells 	cells 	 NNS	I-NP
,  	,  	 ,	O
protects  	protects  	 VBZ	O
retina  	retina  	 JJ	B-NP
neurons  	neurons  	 NNS	I-NP
( 	( 	 -LRB-	O
including  	including  	 VBG	B-NP
photoreceptors 	photoreceptors 	 NN	I-NP
)  	)  	 -RRB-	O
from  	from  	 IN	O
death  	death  	 NN	O
by  	by  	 IN	O
apoptosis  	apoptosis  	 NN	B-NP
and  	and  	 CC	O
other  	other  	 JJ	O
insults 	insults 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
has  	has  	 VBZ	O
a  	a  	 DT	O
morphogenetic  	morphogenetic  	 JJ	B-NP
effect  	effect  	 NN	I-NP
on  	on  	 IN	O
photoreceptor  	photoreceptor  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
[  	[  	 -LRB-	O
3  	3  	 CD	O
4  	4  	 CD	O
5  	5  	 CD	O
6  	6  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
It  	It  	 PRP	O
also  	also  	 RB	O
has  	has  	 VBZ	O
neurotrophic  	neurotrophic  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
on  	on  	 IN	O
neurons  	neurons  	 NN	B-NP
from  	from  	 IN	O
the  	the  	 DT	O
cerebellum 	cerebellum 	 NN	B-NP
,  	,  	 ,	O
hippocampus  	hippocampus  	 NN	B-NP
and  	and  	 CC	O
spinal  	spinal  	 JJ	B-NP
cord  	cord  	 NN	I-NP
[  	[  	 -LRB-	O
7  	7  	 CD	O
8  	8  	 CD	O
9  	9  	 CD	O
10  	10  	 CD	O
11  	11  	 CD	O
12  	12  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
intact  	intact  	 JJ	O
retina 	retina 	 NN	B-NP
,  	,  	 ,	O
this  	this  	 DT	O
factor  	factor  	 NN	B-NP
is  	is  	 VBZ	O
identified  	identified  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
secreted  	secreted  	 JJ	O
protein  	protein  	 NN	B-NP
associated  	associated  	 VBN	O
by  	by  	 IN	O
ionic  	ionic  	 JJ	B-NP
interactions  	interactions  	 NNS	I-NP
with  	with  	 IN	O
the  	the  	 DT	O
interphotoreceptor  	interphotoreceptor  	 JJ	B-NP
matrix  	matrix  	 NNS	I-NP
[  	[  	 -LRB-	O
13  	13  	 CD	O
14  	14  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
where  	where  	 WRB	O
GAGs  	GAGs  	 NNS	O
are  	are  	 VBP	O
the  	the  	 DT	O
major  	major  	 JJ	O
polyanionic  	polyanionic  	 JJ	B-NP
components 	components 	 NNS	I-NP
.  	.  	 .	O
Biochemically 	Biochemically 	 NNP	O
,  	,  	 ,	O
PEDF  	PEDF  	 NNP	B-NP
is  	is  	 VBZ	O
a  	a  	 DT	O
50-kDa  	50-kDa  	 JJ	O
glycoprotein  	glycoprotein  	 NN	O
with  	with  	 IN	O
structural  	structural  	 JJ	B-NP
homology  	homology  	 NN	I-NP
to  	to  	 TO	O
members  	members  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
serine-protease  	serine-protease  	 JJ	B-NP
inhibitor  	inhibitor  	 NNS	I-NP
( 	( 	 -LRB-	O
serpin 	serpin 	 LS	B-NP
)  	)  	 -RRB-	O
superfamily  	superfamily  	 NNS	O
[  	[  	 -LRB-	O
3  	3  	 CD	O
15  	15  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
it  	it  	 PRP	O
has  	has  	 VBZ	O
no  	no  	 DT	O
inhibitory  	inhibitory  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
on  	on  	 IN	O
proteases 	proteases 	 NN	B-NP
.  	.  	 .	O
Its  	Its  	 PRP$	O
neurotrophic  	neurotrophic  	 JJ	B-NP
activities  	activities  	 NNS	I-NP
are  	are  	 VBP	O
independent  	independent  	 JJ	O
of  	of  	 IN	O
its  	its  	 PRP$	O
protease  	protease  	 JJ	B-NP
inhibition  	inhibition  	 JJ	I-NP
potential  	potential  	 NN	I-NP
but  	but  	 CC	O
dependent  	dependent  	 JJ	O
on  	on  	 IN	O
its  	its  	 PRP$	O
interaction  	interaction  	 NN	O
with  	with  	 IN	O
cell-surface  	cell-surface  	 JJ	B-NP
receptors  	receptors  	 NNS	I-NP
[  	[  	 -LRB-	O
9  	9  	 CD	O
12  	12  	 CD	O
16  	16  	 CD	O
17  	17  	 CD	O
18  	18  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
PEDF  	PEDF  	 NNP	B-NP
has  	has  	 VBZ	O
high  	high  	 JJ	O
binding  	binding  	 JJ	O
affinity  	affinity  	 NN	B-NP
for  	for  	 IN	I-NP
cell-surface  	cell-surface  	 JJ	I-NP
receptors  	receptors  	 NNS	I-NP
in  	in  	 IN	O
human  	human  	 JJ	O
retinoblastoma  	retinoblastoma  	 NN	B-NP
Y-79  	Y-79  	 CD	I-NP
cells  	cells  	 NNS	I-NP
( 	( 	 -LRB-	O
K  	K  	 NNP	O
d  	d  	 SYM	O
=  	=  	 SYM	O
2.7  	2.7  	 CD	O
nM 	nM 	 NN	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
which  	which  	 WDT	O
is  	is  	 VBZ	O
mediated  	mediated  	 VBN	O
by  	by  	 IN	O
interactions  	interactions  	 NNS	B-NP
between  	between  	 IN	O
a  	a  	 DT	O
region  	region  	 NN	O
spanning  	spanning  	 VBG	O
amino  	amino  	 JJ	B-NP
acid  	acid  	 NN	I-NP
positions  	positions  	 NNS	I-NP
78-121  	78-121  	 VBP	O
of  	of  	 IN	O
the  	the  	 DT	O
PEDF  	PEDF  	 NNP	B-NP
polypeptide  	polypeptide  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
extracellular  	extracellular  	 JJ	B-NP
domains  	domains  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
receptor  	receptor  	 NN	I-NP
protein  	protein  	 NN	I-NP
[  	[  	 -LRB-	O
18  	18  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Blockage  	Blockage  	 NNP	O
of  	of  	 IN	O
these  	these  	 DT	O
interactions  	interactions  	 NN	B-NP
inhibits  	inhibits  	 VBD	O
the  	the  	 DT	O
PEDF  	PEDF  	 NNP	B-NP
neurotrophic  	neurotrophic  	 NN	I-NP
effects 	effects 	 NNS	I-NP
.  	.  	 .	O
PEDF  	PEDF  	 NNP	B-NP
also  	also  	 RB	O
has  	has  	 VBZ	O
binding  	binding  	 JJ	O
affinity  	affinity  	 NN	B-NP
for  	for  	 IN	O
GAGs 	GAGs 	 NNP	O
,  	,  	 ,	O
such  	such  	 JJ	O
as 	as 	 RB	O
,  	,  	 ,	O
heparin 	heparin 	 NN	B-NP
,  	,  	 ,	O
heparin-  	heparin-  	 JJ	O
and  	and  	 CC	O
chondroitin-sulfates 	chondroitin-sulfates 	 JJ	B-NP
,  	,  	 ,	O
but  	but  	 CC	O
this  	this  	 DT	O
affinity  	affinity  	 NN	B-NP
is  	is  	 VBZ	O
~1000-fold  	~1000-fold  	 RB	O
lower  	lower  	 JJR	O
than  	than  	 IN	O
for  	for  	 IN	O
the  	the  	 DT	O
receptor  	receptor  	 NN	B-NP
( 	( 	 -LRB-	O
e.g. 	e.g. 	 NNP	O
,  	,  	 ,	O
K  	K  	 NNP	O
d  	d  	 SYM	O
4  	4  	 CD	O
μM  	μM  	 NN	O
for  	for  	 IN	O
the  	the  	 DT	O
heparin-PEDF  	heparin-PEDF  	 JJ	O
interactions 	interactions 	 NNS	O
)  	)  	 -RRB-	O
[  	[  	 -LRB-	O
14  	14  	 CD	O
19  	19  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
binding  	binding  	 JJ	O
to  	to  	 TO	O
GAGs  	GAGs  	 NNP	O
is  	is  	 VBZ	O
mediated  	mediated  	 VBN	O
by  	by  	 IN	O
ionic  	ionic  	 JJ	B-NP
interactions  	interactions  	 NNS	I-NP
between  	between  	 IN	O
an  	an  	 DT	O
area  	area  	 NN	O
clustered  	clustered  	 VBN	O
with  	with  	 IN	O
positively  	positively  	 RB	O
charged  	charged  	 VBN	O
lysines  	lysines  	 VBN	O
of  	of  	 IN	O
PEDF  	PEDF  	 NNP	B-NP
and  	and  	 CC	O
the  	the  	 DT	O
negatively  	negatively  	 RB	O
charged  	charged  	 VBN	O
GAGs 	GAGs 	 JJ	O
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
PEDF  	PEDF  	 NNP	B-NP
spatial  	spatial  	 JJ	I-NP
structure 	structure 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
putative  	putative  	 JJ	B-NP
GAG  	GAG  	 NNP	I-NP
binding  	binding  	 JJ	O
domain  	domain  	 NN	O
is  	is  	 VBZ	O
distinct  	distinct  	 VBN	O
from  	from  	 IN	O
and  	and  	 CC	O
non-overlapping  	non-overlapping  	 JJ	B-NP
with  	with  	 IN	O
the  	the  	 DT	O
neurotrophic  	neurotrophic  	 JJ	O
active  	active  	 JJ	O
region  	region  	 NN	O
[  	[  	 -LRB-	O
14  	14  	 CD	O
20  	20  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Because  	Because  	 IN	O
PEDF  	PEDF  	 NNP	B-NP
coexists  	coexists  	 NN	O
with  	with  	 IN	O
GAGs  	GAGs  	 JJ	O
in  	in  	 IN	O
extracellular  	extracellular  	 JJ	B-NP
matrices  	matrices  	 NN	I-NP
and  	and  	 CC	O
has  	has  	 VBZ	O
binding  	binding  	 JJ	O
affinity  	affinity  	 NN	B-NP
for  	for  	 IN	O
them 	them 	 PRP	O
,  	,  	 ,	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
of  	of  	 IN	O
interest  	interest  	 NN	O
to  	to  	 TO	O
investigate  	investigate  	 VB	O
the  	the  	 DT	O
role  	role  	 NN	O
of  	of  	 IN	O
GAGs  	GAGs  	 JJ	O
on  	on  	 IN	O
PEDF  	PEDF  	 NNP	B-NP
activity 	activity 	 NN	I-NP
.  	.  	 .	O
Given  	Given  	 VBN	O
that  	that  	 IN	O
binding  	binding  	 VBG	O
to  	to  	 TO	O
cell-surface  	cell-surface  	 JJ	B-NP
receptors  	receptors  	 NN	I-NP
is  	is  	 VBZ	O
the  	the  	 DT	O
first  	first  	 JJ	O
step  	step  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
biological  	biological  	 JJ	B-NP
activity  	activity  	 NN	I-NP
of  	of  	 IN	I-NP
PEDF 	PEDF 	 NNP	I-NP
,  	,  	 ,	O
we  	we  	 PRP	O
used  	used  	 VBD	O
human  	human  	 JJ	O
retinoblastoma  	retinoblastoma  	 NN	B-NP
Y-79  	Y-79  	 CD	I-NP
cells  	cells  	 NNS	I-NP
and  	and  	 CC	O
their  	their  	 PRP$	O
conditioned  	conditioned  	 JJ	O
media  	media  	 NNS	O
( 	( 	 -LRB-	O
CM 	CM 	 NNP	O
)  	)  	 -RRB-	O
as  	as  	 IN	O
sources  	sources  	 NNS	O
of  	of  	 IN	O
functional  	functional  	 JJ	B-NP
PEDF  	PEDF  	 NN	I-NP
receptors  	receptors  	 NNS	I-NP
and  	and  	 CC	O
extracellular  	extracellular  	 JJ	B-NP
matrix  	matrix  	 JJ	I-NP
components 	components 	 NNS	I-NP
,  	,  	 ,	O
respectively 	respectively 	 RB	O
,  	,  	 ,	O
to  	to  	 TO	O
examine  	examine  	 VB	O
the  	the  	 DT	O
GAG  	GAG  	 NNP	O
content  	content  	 NN	O
in  	in  	 IN	O
CM  	CM  	 NNP	O
and  	and  	 CC	O
their  	their  	 PRP$	O
effects  	effects  	 NNS	O
on  	on  	 IN	O
PEDF  	PEDF  	 NNP	B-NP
ligand-receptor  	ligand-receptor  	 JJ	I-NP
interactions 	interactions 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
data  	data  	 NNS	O
suggest  	suggest  	 VBP	O
that  	that  	 IN	O
heparan  	heparan  	 JJ	B-NP
sulfate  	sulfate  	 NN	I-NP
participates  	participates  	 VBZ	O
in  	in  	 IN	O
the  	the  	 DT	O
formation  	formation  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
PEDF  	PEDF  	 NNP	B-NP
binding  	binding  	 JJ	O
complex  	complex  	 NN	O
with  	with  	 IN	O
its  	its  	 PRP$	O
cell-surface  	cell-surface  	 JJ	B-NP
receptor 	receptor 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
constitutes  	constitutes  	 VBZ	O
a  	a  	 DT	O
positive  	positive  	 JJ	B-NP
modulator  	modulator  	 NN	I-NP
for  	for  	 IN	I-NP
the  	the  	 DT	I-NP
PEDF-receptor  	PEDF-receptor  	 JJ	I-NP
interactions 	interactions 	 NNS	I-NP
.  	.  	 .	O
Results  	Results  	 NNS	O
Complex  	Complex  	 JJ	B-NP
formation  	formation  	 NN	I-NP
between  	between  	 IN	O
PEDF  	PEDF  	 NNP	B-NP
and  	and  	 CC	O
component 	component 	 NN	B-NP
( 	( 	 -LRB-	I-NP
s 	s 	 LS	I-NP
)  	)  	 -RRB-	I-NP
in  	in  	 IN	O
media  	media  	 NNS	O
conditioned  	conditioned  	 VBN	O
by  	by  	 IN	O
retinoblastoma  	retinoblastoma  	 NN	B-NP
cells  	cells  	 NNS	I-NP
To  	To  	 TO	O
determine  	determine  	 VB	O
whether  	whether  	 IN	O
PEDF  	PEDF  	 NNP	B-NP
interacts  	interacts  	 NN	O
with  	with  	 IN	O
component 	component 	 NN	B-NP
( 	( 	 -LRB-	I-NP
s 	s 	 LS	I-NP
)  	)  	 -RRB-	I-NP
in  	in  	 IN	O
media  	media  	 NNS	O
conditioned  	conditioned  	 VBN	O
by  	by  	 IN	O
retinoblastoma  	retinoblastoma  	 NN	B-NP
cells  	cells  	 NNS	I-NP
( 	( 	 -LRB-	O
CM 	CM 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
we  	we  	 PRP	O
used  	used  	 VBD	O
an  	an  	 DT	O
ultrafiltration  	ultrafiltration  	 JJ	B-NP
assay 	assay 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
assay 	assay 	 NN	B-NP
,  	,  	 ,	O
soluble  	soluble  	 JJ	B-NP
PEDF  	PEDF  	 NN	I-NP
of  	of  	 IN	O
50-kDa  	50-kDa  	 NNP	O
is  	is  	 VBZ	O
filtered  	filtered  	 VBN	O
through  	through  	 IN	O
a  	a  	 DT	O
membrane  	membrane  	 NN	O
with  	with  	 IN	O
an  	an  	 DT	O
exclusion  	exclusion  	 NN	B-NP
limit  	limit  	 NN	I-NP
of  	of  	 IN	I-NP
MW  	MW  	 NNP	I-NP
100,000 	100,000 	 CD	O
,  	,  	 ,	O
however  	however  	 RB	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
retained  	retained  	 VBN	O
upon  	upon  	 IN	O
formation  	formation  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
complex  	complex  	 JJ	O
larger  	larger  	 JJR	O
than  	than  	 IN	O
this  	this  	 DT	O
limit  	limit  	 NN	O
[  	[  	 -LRB-	O
14  	14  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
binding  	binding  	 JJ	O
reactions  	reactions  	 NNS	O
were  	were  	 VBD	O
with  	with  	 IN	O
a  	a  	 DT	O
given  	given  	 VBN	O
125I-PEDF  	125I-PEDF  	 CD	O
concentration  	concentration  	 NN	O
and  	and  	 CC	O
CM 	CM 	 NNP	O
.  	.  	 .	O
Incubations  	Incubations  	 NNP	O
were  	were  	 VBD	O
at  	at  	 IN	O
4°C  	4°C  	 CD	O
to  	to  	 TO	O
minimize  	minimize  	 VB	O
enzymatic  	enzymatic  	 JJ	B-NP
degradation  	degradation  	 NN	I-NP
of  	of  	 IN	O
proteins  	proteins  	 NNS	O
and  	and  	 CC	O
glycosaminglycans  	glycosaminglycans  	 NN	B-NP
during  	during  	 IN	O
the  	the  	 DT	O
reaction 	reaction 	 NN	O
.  	.  	 .	O
We  	We  	 PRP	O
found  	found  	 VBD	O
that  	that  	 IN	O
22 	22 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
125I-PEDF  	125I-PEDF  	 NNP	O
was  	was  	 VBD	O
retained  	retained  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
membrane  	membrane  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
concentrated  	concentrated  	 JJ	O
CM 	CM 	 NNP	O
,  	,  	 ,	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
only  	only  	 RB	O
4 	4 	 CD	O
%  	%  	 NN	O
retention  	retention  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
defined  	defined  	 JJ	O
medium  	medium  	 NN	O
( 	( 	 -LRB-	O
non-conditioned  	non-conditioned  	 JJ	B-NP
medium 	medium 	 NN	I-NP
)  	)  	 -RRB-	O
concentrated  	concentrated  	 VBN	O
in  	in  	 IN	O
an  	an  	 DT	O
identical  	identical  	 JJ	O
fashion 	fashion 	 NN	O
.  	.  	 .	O
Specific  	Specific  	 JJ	B-NP
retention 	retention 	 NN	I-NP
,  	,  	 ,	O
termed  	termed  	 VBD	B-NP
PEDF  	PEDF  	 NNP	I-NP
bound 	bound 	 NN	I-NP
,  	,  	 ,	O
was  	was  	 VBD	O
calculated  	calculated  	 VBN	O
by  	by  	 IN	O
subtracting  	subtracting  	 VBG	O
the  	the  	 DT	O
retention  	retention  	 NN	O
in  	in  	 IN	O
defined  	defined  	 JJ	O
media  	media  	 NNS	O
from  	from  	 IN	O
that  	that  	 DT	O
in  	in  	 IN	O
CM 	CM 	 NNP	O
.  	.  	 .	O
Figure  	Figure  	 NN	O
1shows  	1shows  	 NN	O
that  	that  	 IN	O
PEDF  	PEDF  	 NNP	B-NP
was  	was  	 VBD	O
specifically  	specifically  	 RB	O
retained  	retained  	 VBN	O
when  	when  	 WRB	O
mixed  	mixed  	 VBN	O
with  	with  	 IN	O
soluble  	soluble  	 JJ	B-NP
conditioned  	conditioned  	 JJ	I-NP
media  	media  	 NNS	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
value  	value  	 NN	O
for  	for  	 IN	O
PEDF  	PEDF  	 NNP	B-NP
bound  	bound  	 NN	I-NP
increased  	increased  	 VBD	O
proportionally  	proportionally  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
concentration  	concentration  	 NN	B-NP
factor  	factor  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
media  	media  	 NNS	O
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
1A 	1A 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Interestingly 	Interestingly 	 RB	O
,  	,  	 ,	O
protease  	protease  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
CM  	CM  	 NNP	O
did  	did  	 VBD	O
not  	not  	 RB	O
abolish  	abolish  	 VB	O
the  	the  	 DT	O
binding  	binding  	 NN	O
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
1B 	1B 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
These  	These  	 DT	O
observations  	observations  	 NNS	B-NP
revealed  	revealed  	 VBD	O
that  	that  	 IN	O
the  	the  	 DT	O
retained  	retained  	 JJ	O
forms  	forms  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
CM  	CM  	 NNP	O
were  	were  	 VBD	O
PEDF  	PEDF  	 NNP	B-NP
complexes  	complexes  	 VBD	I-NP
≥  	≥  	 CD	O
100-kDa 	100-kDa 	 CD	O
,  	,  	 ,	O
and  	and  	 CC	O
that  	that  	 IN	O
the  	the  	 DT	O
majority  	majority  	 NN	O
of  	of  	 IN	O
these  	these  	 DT	O
complexes  	complexes  	 NNS	O
were  	were  	 VBD	O
formed  	formed  	 VBN	O
with  	with  	 IN	O
soluble  	soluble  	 JJ	O
CM  	CM  	 NN	O
components  	components  	 NNS	O
other  	other  	 JJ	O
than  	than  	 IN	O
proteins 	proteins 	 NNS	O
.  	.  	 .	O
Heparin  	Heparin  	 NNP	B-NP
and  	and  	 CC	O
HS  	HS  	 NNP	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
conditioned  	conditioned  	 JJ	O
media  	media  	 NNS	O
with  	with  	 IN	O
affinity  	affinity  	 NN	B-NP
for  	for  	 IN	I-NP
PEDF  	PEDF  	 NNP	I-NP
GAGs  	GAGs  	 NNP	I-NP
and  	and  	 CC	O
polyanions  	polyanions  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
CM  	CM  	 NNP	O
were  	were  	 VBD	O
fractionated  	fractionated  	 VBN	O
by  	by  	 IN	O
anion-exchange  	anion-exchange  	 JJ	B-NP
column  	column  	 NN	I-NP
chromatography  	chromatography  	 VBZ	O
followed  	followed  	 VBN	O
by  	by  	 IN	O
PEDF-affinity  	PEDF-affinity  	 JJ	B-NP
column  	column  	 NN	I-NP
chromatography  	chromatography  	 NNS	I-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 CD	O
2 	2 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
GAG  	GAG  	 NNP	O
content  	content  	 NN	O
was  	was  	 VBD	O
followed  	followed  	 VBN	O
by  	by  	 IN	O
staining  	staining  	 NN	O
with  	with  	 IN	O
Toluidine  	Toluidine  	 NNP	B-NP
Blue-O  	Blue-O  	 NNP	I-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
2C 	2C 	 NNP	O
, 	, 	 ,	O
2D 	2D 	 NNP	O
, 	, 	 ,	O
2E 	2E 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
final  	final  	 JJ	B-NP
fraction  	fraction  	 NN	I-NP
( 	( 	 -LRB-	O
CM  	CM  	 NNP	O
PEDF 	PEDF 	 NNP	B-NP
)  	)  	 -RRB-	O
contained  	contained  	 VBD	O
components  	components  	 NNS	O
with  	with  	 IN	O
binding  	binding  	 JJ	O
affinity  	affinity  	 NN	B-NP
for  	for  	 IN	I-NP
PEDF  	PEDF  	 NNP	I-NP
that  	that  	 IN	O
stained  	stained  	 NN	O
with  	with  	 IN	O
Toluidine  	Toluidine  	 NNP	B-NP
Blue-O  	Blue-O  	 NNP	I-NP
and  	and  	 CC	O
migrated  	migrated  	 NN	O
as  	as  	 IN	O
high  	high  	 JJ	O
molecular  	molecular  	 JJ	B-NP
weight  	weight  	 NN	I-NP
GAGs 	GAGs 	 NN	I-NP
.  	.  	 .	O
To  	To  	 TO	O
determine  	determine  	 VB	O
the  	the  	 DT	O
type  	type  	 NN	O
of  	of  	 IN	O
sulfated  	sulfated  	 JJ	B-NP
GAG  	GAG  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
media 	media 	 NNS	O
,  	,  	 ,	O
we  	we  	 PRP	O
designed  	designed  	 VBD	O
a  	a  	 DT	O
spectrophotometric  	spectrophotometric  	 JJ	B-NP
assay  	assay  	 NNS	I-NP
using  	using  	 VBG	O
heparinase  	heparinase  	 NNS	B-NP
and  	and  	 CC	O
heparitinase 	heparitinase 	 NN	B-NP
,  	,  	 ,	O
specific  	specific  	 JJ	O
degrading  	degrading  	 JJ	O
enzymes  	enzymes  	 NN	O
for  	for  	 IN	O
heparin  	heparin  	 NN	B-NP
and  	and  	 CC	O
HS 	HS 	 NNP	B-NP
,  	,  	 ,	O
respectively  	respectively  	 RB	O
( 	( 	 -LRB-	O
Fig.  	Fig.  	 CD	O
3 	3 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
activities  	activities  	 NNS	O
of  	of  	 IN	O
both  	both  	 DT	O
GAG  	GAG  	 NNP	O
lyases  	lyases  	 VBD	O
reached  	reached  	 VBN	O
a  	a  	 DT	O
plateau  	plateau  	 NN	O
by  	by  	 IN	O
one  	one  	 CD	O
hour  	hour  	 NN	O
of  	of  	 IN	O
incubation  	incubation  	 NNS	O
( 	( 	 -LRB-	O
Figs.  	Figs.  	 NNP	O
3A 	3A 	 NNP	O
, 	, 	 ,	O
3C 	3C 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
the  	the  	 DT	O
degradation  	degradation  	 NN	O
of  	of  	 IN	O
GAG  	GAG  	 NNP	O
substrates  	substrates  	 NN	O
between  	between  	 IN	O
0-30  	0-30  	 CD	O
μg  	μg  	 NNS	B-NP
was  	was  	 VBD	O
linear 	linear 	 VBN	B-NP
.  	.  	 .	O
Both  	Both  	 DT	O
CM  	CM  	 NNP	O
and  	and  	 CC	O
CM  	CM  	 NNP	O
PEDFcontained  	PEDFcontained  	 JJ	B-NP
substrates  	substrates  	 NN	I-NP
for  	for  	 IN	I-NP
heparinase  	heparinase  	 NN	I-NP
and  	and  	 CC	O
heparitinase  	heparitinase  	 NNS	B-NP
( 	( 	 -LRB-	O
Figs.  	Figs.  	 NNP	O
3B 	3B 	 NNP	O
, 	, 	 ,	O
3D 	3D 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
amount  	amount  	 NN	O
of  	of  	 IN	O
GAGs  	GAGs  	 NNP	O
was  	was  	 VBD	O
determined  	determined  	 VBN	O
by  	by  	 IN	O
comparison  	comparison  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
amount  	amount  	 NN	O
of  	of  	 IN	O
Δ  	Δ  	 NNP	O
4-hexuronate  	4-hexuronate  	 NNP	O
produced  	produced  	 VBD	O
with  	with  	 IN	O
CM  	CM  	 NNP	O
samples  	samples  	 NNS	O
to  	to  	 TO	O
the  	the  	 DT	O
standard  	standard  	 JJ	O
curves  	curves  	 NN	O
with  	with  	 IN	O
commercial  	commercial  	 JJ	B-NP
GAGs 	GAGs 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
estimated  	estimated  	 JJ	O
content  	content  	 NN	O
of  	of  	 IN	O
GAGs  	GAGs  	 JJ	O
in  	in  	 IN	O
CM  	CM  	 NNP	O
varied  	varied  	 VBD	O
between  	between  	 IN	O
12.4-22.7  	12.4-22.7  	 CD	O
μg 	μg 	 CD	B-NP
/ 	/ 	 CD	I-NP
ml  	ml  	 NN	I-NP
for  	for  	 IN	I-NP
heparin  	heparin  	 NN	I-NP
and  	and  	 CC	O
between  	between  	 IN	O
9-10  	9-10  	 CD	O
μg 	μg 	 CD	B-NP
/ 	/ 	 CD	I-NP
ml  	ml  	 NN	I-NP
for  	for  	 IN	I-NP
HS-like  	HS-like  	 JJ	I-NP
molecules 	molecules 	 NNS	I-NP
,  	,  	 ,	O
among  	among  	 IN	O
media  	media  	 NNS	O
conditioned  	conditioned  	 VBN	O
by  	by  	 IN	O
three  	three  	 CD	O
different  	different  	 JJ	O
batches  	batches  	 NNS	O
of  	of  	 IN	O
Y-79  	Y-79  	 CD	B-NP
cells 	cells 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
estimated  	estimated  	 JJ	O
GAG  	GAG  	 NNP	O
content  	content  	 NN	O
in  	in  	 IN	O
CM  	CM  	 NNP	O
PEDFranged  	PEDFranged  	 FW	B-NP
0.2-1.8  	0.2-1.8  	 FW	O
μg 	μg 	 FW	B-NP
/ 	/ 	 FW	I-NP
μl  	μl  	 FW	I-NP
and  	and  	 CC	O
0.1-0.4  	0.1-0.4  	 CD	O
μg 	μg 	 CD	B-NP
/ 	/ 	 CD	I-NP
μl  	μl  	 NN	I-NP
for  	for  	 IN	I-NP
heparin  	heparin  	 NN	I-NP
and  	and  	 CC	O
HS 	HS 	 NNP	B-NP
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
Similar  	Similar  	 JJ	O
assays  	assays  	 NN	O
were  	were  	 VBD	O
followed  	followed  	 VBN	O
with  	with  	 IN	O
chondroitinase  	chondroitinase  	 JJ	B-NP
ABC 	ABC 	 NNP	I-NP
,  	,  	 ,	O
but  	but  	 CC	O
its  	its  	 PRP$	O
substrates 	substrates 	 NN	O
,  	,  	 ,	O
ΔDi4S 	ΔDi4S 	 NNP	O
,  	,  	 ,	O
dermatan  	dermatan  	 NN	B-NP
and  	and  	 CC	O
ΔDi6S 	ΔDi6S 	 NNP	O
,  	,  	 ,	O
in  	in  	 IN	O
CM  	CM  	 NNP	O
were  	were  	 VBD	O
below  	below  	 IN	O
detection  	detection  	 JJ	B-NP
limits 	limits 	 NNS	I-NP
.  	.  	 .	O
These  	These  	 DT	O
results  	results  	 NNS	O
demonstrated  	demonstrated  	 VBN	O
that  	that  	 IN	O
CM  	CM  	 NNP	O
and  	and  	 CC	O
CM  	CM  	 NNP	O
PEDFcontained  	PEDFcontained  	 NNP	O
heparin-  	heparin-  	 NNP	B-NP
and  	and  	 CC	O
HS-like  	HS-like  	 JJ	B-NP
molecules 	molecules 	 NNS	I-NP
,  	,  	 ,	O
demonstrating  	demonstrating  	 VBG	O
that  	that  	 IN	O
Y-79  	Y-79  	 CD	B-NP
cells  	cells  	 NNS	I-NP
produced  	produced  	 VBD	O
GAGs  	GAGs  	 JJ	O
with  	with  	 IN	O
binding  	binding  	 JJ	O
affinity  	affinity  	 NN	B-NP
for  	for  	 IN	I-NP
PEDF 	PEDF 	 NNP	I-NP
.  	.  	 .	O
Media  	Media  	 NNS	O
conditioned  	conditioned  	 VBN	O
by  	by  	 IN	O
retinoblastoma  	retinoblastoma  	 NN	B-NP
cells  	cells  	 NNS	I-NP
enhances  	enhances  	 VBZ	O
the  	the  	 DT	O
125I-PEDF  	125I-PEDF  	 JJ	O
binding  	binding  	 NN	O
to  	to  	 TO	O
cell-surface  	cell-surface  	 JJ	B-NP
receptors  	receptors  	 NNS	I-NP
We  	We  	 PRP	O
have  	have  	 VBP	O
demonstrated  	demonstrated  	 VBN	O
previously  	previously  	 RB	O
that  	that  	 IN	O
biologically  	biologically  	 JJ	O
active  	active  	 JJ	O
125I-PEDF  	125I-PEDF  	 NN	O
binds  	binds  	 VBZ	O
specifically 	specifically 	 RB	O
,  	,  	 ,	O
competitively  	competitively  	 RB	O
and  	and  	 CC	O
with  	with  	 IN	O
high  	high  	 JJ	O
affinity  	affinity  	 NN	B-NP
to  	to  	 TO	O
cell-surface  	cell-surface  	 JJ	B-NP
receptors  	receptors  	 NNS	I-NP
of  	of  	 IN	I-NP
Y-79  	Y-79  	 CD	I-NP
cells  	cells  	 NNS	I-NP
[  	[  	 -LRB-	O
18  	18  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Because  	Because  	 IN	O
the  	the  	 DT	O
reaction  	reaction  	 NN	B-NP
conditions  	conditions  	 NNS	I-NP
were  	were  	 VBD	O
identical  	identical  	 JJ	O
to  	to  	 TO	O
those  	those  	 DT	O
used  	used  	 VBN	O
for  	for  	 IN	O
biological  	biological  	 JJ	B-NP
assays 	assays 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
reactions  	reactions  	 NNS	O
were  	were  	 VBD	O
performed  	performed  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
media  	media  	 NNS	O
conditioned  	conditioned  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
cells  	cells  	 NNS	O
for  	for  	 IN	O
16  	16  	 CD	O
hours  	hours  	 NNS	O
( 	( 	 -LRB-	O
CM 	CM 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
We  	We  	 PRP	O
investigated  	investigated  	 VBD	O
the  	the  	 DT	O
effect  	effect  	 NN	O
of  	of  	 IN	O
components  	components  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
CM 	CM 	 NNP	O
,  	,  	 ,	O
a  	a  	 DT	O
source  	source  	 NN	O
of  	of  	 IN	O
extracellular  	extracellular  	 JJ	B-NP
matrix 	matrix 	 NN	I-NP
,  	,  	 ,	O
on  	on  	 IN	O
the  	the  	 DT	O
PEDF-receptor  	PEDF-receptor  	 JJ	B-NP
interactions  	interactions  	 NNS	I-NP
using  	using  	 VBG	O
CM  	CM  	 NNP	O
and  	and  	 CC	O
non-conditioned  	non-conditioned  	 JJ	B-NP
defined  	defined  	 JJ	O
media  	media  	 NNS	O
in  	in  	 IN	O
radioligand  	radioligand  	 JJ	B-NP
binding  	binding  	 JJ	I-NP
assays 	assays 	 NN	I-NP
.  	.  	 .	O
Comparison  	Comparison  	 NN	O
of  	of  	 IN	O
reactions  	reactions  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
absence  	absence  	 NN	B-NP
and  	and  	 CC	O
presence  	presence  	 NN	O
of  	of  	 IN	O
CM  	CM  	 NNP	O
showed  	showed  	 VBD	O
that  	that  	 IN	O
the  	the  	 DT	O
specific  	specific  	 JJ	O
PEDF-binding  	PEDF-binding  	 JJ	B-NP
to  	to  	 TO	O
Y-79  	Y-79  	 CD	B-NP
cell-surface  	cell-surface  	 JJ	I-NP
receptors  	receptors  	 NNS	I-NP
was  	was  	 VBD	O
6.8-fold  	6.8-fold  	 CD	O
higher  	higher  	 JJR	O
with  	with  	 IN	O
conditioned  	conditioned  	 JJ	O
medium  	medium  	 NN	O
than  	than  	 IN	O
with  	with  	 IN	O
defined  	defined  	 JJ	O
medium  	medium  	 NN	O
( 	( 	 -LRB-	O
Fig.  	Fig.  	 CD	O
4 	4 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Note  	Note  	 NN	O
that  	that  	 IN	O
with  	with  	 IN	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
method  	method  	 NN	O
used 	used 	 VBN	O
,  	,  	 ,	O
the  	the  	 DT	O
amount  	amount  	 NN	O
of  	of  	 IN	O
125I-PEDF  	125I-PEDF  	 NNP	O
retained  	retained  	 VBD	O
in  	in  	 IN	O
CM  	CM  	 NNP	O
without  	without  	 IN	O
cells  	cells  	 NNS	O
is  	is  	 VBZ	O
the  	the  	 DT	O
same  	same  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
amount  	amount  	 NN	O
of  	of  	 IN	O
non-specific  	non-specific  	 JJ	O
125I-PEDF  	125I-PEDF  	 CD	O
binding  	binding  	 NNS	O
( 	( 	 -LRB-	O
reactions  	reactions  	 NNS	O
with  	with  	 IN	O
cells  	cells  	 NNS	O
and  	and  	 CC	O
in  	in  	 IN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
50-fold  	50-fold  	 CD	O
molar  	molar  	 JJ	B-NP
excess  	excess  	 NN	I-NP
of  	of  	 IN	O
unlabeled  	unlabeled  	 JJ	O
PEDF 	PEDF 	 NNP	B-NP
)  	)  	 -RRB-	O
[  	[  	 -LRB-	O
18  	18  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
indicating  	indicating  	 VBG	B-NP
retention  	retention  	 NN	I-NP
by  	by  	 IN	O
PEI-treated  	PEI-treated  	 JJ	B-NP
glass-fiber  	glass-fiber  	 JJ	I-NP
filters  	filters  	 NNS	I-NP
of  	of  	 IN	I-NP
PEDF-receptor  	PEDF-receptor  	 JJ	I-NP
or  	or  	 CC	O
GAG-PEDF-receptor  	GAG-PEDF-receptor  	 JJ	B-NP
complexes  	complexes  	 NNS	I-NP
rather  	rather  	 RB	O
than  	than  	 IN	O
PEDF-GAG 	PEDF-GAG 	 JJ	B-NP
.  	.  	 .	O
Similar  	Similar  	 JJ	B-NP
results  	results  	 NNS	I-NP
were  	were  	 VBD	O
obtained  	obtained  	 VBN	O
when  	when  	 WRB	O
the  	the  	 DT	O
cell-bound  	cell-bound  	 JJ	O
125I-PEDF  	125I-PEDF  	 NN	O
was  	was  	 VBD	O
separated  	separated  	 VBN	O
by  	by  	 IN	O
centrifugation 	centrifugation 	 NN	B-NP
,  	,  	 ,	O
rather  	rather  	 RB	O
than  	than  	 IN	O
filtration  	filtration  	 NN	O
through  	through  	 IN	O
glass-fiber  	glass-fiber  	 JJ	B-NP
filters 	filters 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
comparing  	comparing  	 VBG	B-NP
reactions  	reactions  	 NNS	I-NP
with  	with  	 IN	O
CM  	CM  	 NNP	O
versus  	versus  	 CC	O
those  	those  	 DT	O
with  	with  	 IN	O
1 	1 	 CD	O
%  	%  	 NN	O
BSA  	BSA  	 NN	B-NP
in  	in  	 IN	O
PBS  	PBS  	 NNP	B-NP
( 	( 	 -LRB-	O
data  	data  	 NNS	O
not  	not  	 RB	O
shown 	shown 	 VBN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
These  	These  	 DT	O
observations  	observations  	 NNS	B-NP
showed  	showed  	 VBD	O
that  	that  	 IN	O
a  	a  	 DT	O
component 	component 	 NN	B-NP
( 	( 	 -LRB-	I-NP
s 	s 	 LS	I-NP
)  	)  	 -RRB-	I-NP
secreted  	secreted  	 NN	I-NP
by  	by  	 IN	O
retinoblastoma  	retinoblastoma  	 NN	B-NP
cells  	cells  	 NNS	I-NP
enhanced  	enhanced  	 VBN	O
the  	the  	 DT	O
PEDF-receptor  	PEDF-receptor  	 JJ	B-NP
interactions 	interactions 	 NNS	I-NP
.  	.  	 .	O
Effect  	Effect  	 NN	O
of  	of  	 IN	O
GAG  	GAG  	 NNP	B-NP
lyases  	lyases  	 NN	I-NP
and  	and  	 CC	O
chlorate  	chlorate  	 NN	B-NP
on  	on  	 IN	O
125I-PEDF  	125I-PEDF  	 CD	O
binding  	binding  	 NN	O
to  	to  	 TO	O
cell-surface  	cell-surface  	 JJ	B-NP
receptors  	receptors  	 NNS	I-NP
To  	To  	 TO	O
deplete  	deplete  	 VB	O
the  	the  	 DT	O
Y-79  	Y-79  	 JJ	B-NP
cell  	cell  	 NN	I-NP
cultures  	cultures  	 NNS	I-NP
of  	of  	 IN	I-NP
HS  	HS  	 NNP	I-NP
and  	and  	 CC	O
heparin-like  	heparin-like  	 JJ	B-NP
GAGs 	GAGs 	 NN	I-NP
,  	,  	 ,	O
we  	we  	 PRP	O
used  	used  	 VBD	O
heparitinase  	heparitinase  	 JJ	O
and  	and  	 CC	O
heparinase 	heparinase 	 NN	B-NP
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
The  	The  	 DT	O
cultures  	cultures  	 NNS	O
were  	were  	 VBD	O
pretreated  	pretreated  	 VBN	O
with  	with  	 IN	O
each  	each  	 DT	O
GAG  	GAG  	 NNP	B-NP
lyase  	lyase  	 NN	I-NP
before  	before  	 IN	O
using  	using  	 VBG	O
them  	them  	 PRP	O
in  	in  	 IN	O
radioligand  	radioligand  	 JJ	B-NP
binding  	binding  	 JJ	I-NP
assays 	assays 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
morphology  	morphology  	 NN	O
and  	and  	 CC	O
viability  	viability  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
cells  	cells  	 NNS	O
were  	were  	 VBD	O
not  	not  	 RB	O
affected  	affected  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
GAG  	GAG  	 NNP	B-NP
lyase  	lyase  	 NN	I-NP
treatments 	treatments 	 NNS	I-NP
.  	.  	 .	O
Figure  	Figure  	 NN	O
5Ashows  	5Ashows  	 NN	O
that  	that  	 IN	O
specific  	specific  	 JJ	O
125I-PEDF  	125I-PEDF  	 CD	O
binding  	binding  	 NNS	O
decreased  	decreased  	 VBD	O
significantly  	significantly  	 RB	O
in  	in  	 IN	O
heparitinase  	heparitinase  	 JJ	B-NP
treated  	treated  	 JJ	I-NP
cultures  	cultures  	 NNS	I-NP
compared  	compared  	 VBN	O
to  	to  	 TO	O
untreated  	untreated  	 VB	O
controls 	controls 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
less  	less  	 RBR	O
drastically  	drastically  	 RB	O
in  	in  	 IN	O
heparinase  	heparinase  	 JJ	B-NP
treated  	treated  	 JJ	I-NP
ones 	ones 	 NNS	I-NP
.  	.  	 .	O
Hyaluronidase  	Hyaluronidase  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
to  	to  	 TO	O
deplete  	deplete  	 VB	O
the  	the  	 DT	O
cultures  	cultures  	 NNS	O
of  	of  	 IN	O
hyaluronan  	hyaluronan  	 NN	B-NP
did  	did  	 VBD	O
not  	not  	 RB	O
have  	have  	 VB	O
an  	an  	 DT	O
effect  	effect  	 NN	O
on  	on  	 IN	O
the  	the  	 DT	O
binding 	binding 	 NN	O
.  	.  	 .	O
These  	These  	 DT	O
results  	results  	 NNS	O
demonstrated  	demonstrated  	 VBD	O
that  	that  	 DT	O
removal  	removal  	 NN	O
of  	of  	 IN	O
heparin 	heparin 	 JJ	O
/ 	/ 	 NNP	O
HS  	HS  	 NNP	O
from  	from  	 IN	O
the  	the  	 DT	O
cell  	cell  	 NN	O
cultures  	cultures  	 NNS	O
decreased  	decreased  	 VBD	O
the  	the  	 DT	O
PEDF  	PEDF  	 NNP	B-NP
binding  	binding  	 VBD	O
to  	to  	 TO	O
receptors  	receptors  	 VB	O
on  	on  	 IN	O
Y-79  	Y-79  	 CD	B-NP
cells 	cells 	 NNS	I-NP
.  	.  	 .	O
Chlorate  	Chlorate  	 NNP	B-NP
is  	is  	 VBZ	O
a  	a  	 DT	O
competitive  	competitive  	 JJ	B-NP
inhibitor  	inhibitor  	 NN	I-NP
of  	of  	 IN	I-NP
ATP-sulfurylase 	ATP-sulfurylase 	 NNP	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
inhibition  	inhibition  	 NN	O
of  	of  	 IN	O
GAG  	GAG  	 NNP	B-NP
sulfation  	sulfation  	 NN	I-NP
in  	in  	 IN	O
cell  	cell  	 NN	O
cultures  	cultures  	 NNS	O
can  	can  	 MD	O
be  	be  	 VB	O
achieved  	achieved  	 VBN	O
by  	by  	 IN	O
pretreatment  	pretreatment  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
cultures  	cultures  	 NNS	O
with  	with  	 IN	O
30  	30  	 CD	O
mM  	mM  	 JJ	B-NP
sodium  	sodium  	 NN	I-NP
chlorate  	chlorate  	 NNS	I-NP
[  	[  	 -LRB-	O
21  	21  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
effect  	effect  	 NN	O
of  	of  	 IN	O
undersulfated  	undersulfated  	 JJ	B-NP
GAGs  	GAGs  	 NN	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
PEDF  	PEDF  	 NNP	B-NP
binding  	binding  	 VBD	O
to  	to  	 TO	O
its  	its  	 PRP$	O
receptor  	receptor  	 NN	B-NP
was  	was  	 VBD	O
examined 	examined 	 VBN	O
.  	.  	 .	O
Cells  	Cells  	 NNS	O
pretreated  	pretreated  	 VBN	O
with  	with  	 IN	O
sodium  	sodium  	 JJ	B-NP
chlorate  	chlorate  	 NN	I-NP
did  	did  	 VBD	O
not  	not  	 RB	O
show  	show  	 VB	O
changes  	changes  	 NNS	O
in  	in  	 IN	O
viability  	viability  	 NN	O
or  	or  	 CC	O
morphology 	morphology 	 NNS	O
;  	;  	 :	O
however 	however 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
resulted  	resulted  	 VBD	O
in  	in  	 IN	O
a  	a  	 DT	O
decrease  	decrease  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
specific  	specific  	 JJ	O
125I-PEDF  	125I-PEDF  	 NN	O
binding  	binding  	 VBG	O
to  	to  	 TO	O
about  	about  	 RB	O
35 	35 	 CD	O
%  	%  	 NN	O
relative  	relative  	 JJ	O
to  	to  	 TO	O
untreated  	untreated  	 VB	O
controls  	controls  	 NNS	O
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
5B 	5B 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Sodium  	Sodium  	 JJ	B-NP
sulfate  	sulfate  	 NN	I-NP
was  	was  	 VBD	O
used  	used  	 VBN	O
to  	to  	 TO	O
recover  	recover  	 VB	O
the  	the  	 DT	O
loss  	loss  	 NN	O
of  	of  	 IN	O
GAG  	GAG  	 NNP	B-NP
sulfation  	sulfation  	 NN	I-NP
by  	by  	 IN	O
chlorate  	chlorate  	 NNS	B-NP
increasing  	increasing  	 VBG	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
to  	to  	 TO	O
55 	55 	 CD	O
%  	%  	 NN	O
maximal  	maximal  	 NN	O
with  	with  	 IN	O
10  	10  	 CD	O
mM  	mM  	 JJ	O
sulfate  	sulfate  	 JJ	B-NP
additions 	additions 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
data  	data  	 NNS	O
revealed  	revealed  	 VBD	O
that  	that  	 DT	O
inhibition  	inhibition  	 NN	O
of  	of  	 IN	O
sulfation  	sulfation  	 NN	B-NP
of  	of  	 IN	O
GAGs  	GAGs  	 NNP	O
reduced  	reduced  	 VBD	O
the  	the  	 DT	O
PEDF  	PEDF  	 NNP	B-NP
binding  	binding  	 VBD	O
to  	to  	 TO	O
cell-surface  	cell-surface  	 JJ	B-NP
receptors  	receptors  	 NNS	I-NP
of  	of  	 IN	I-NP
Y-79  	Y-79  	 CD	I-NP
cells 	cells 	 NNS	I-NP
,  	,  	 ,	O
with  	with  	 IN	O
about  	about  	 IN	O
20 	20 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
specific  	specific  	 JJ	O
inhibition 	inhibition 	 NN	O
.  	.  	 .	O
Thus 	Thus 	 RB	O
,  	,  	 ,	O
these  	these  	 DT	O
observations  	observations  	 NNS	B-NP
implied  	implied  	 VBN	O
that  	that  	 IN	O
HS 	HS 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
heparin  	heparin  	 NN	I-NP
might  	might  	 MD	O
play  	play  	 VB	O
a  	a  	 DT	O
functional  	functional  	 JJ	B-NP
role  	role  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
binding  	binding  	 NN	O
of  	of  	 IN	O
PEDF  	PEDF  	 NNP	B-NP
to  	to  	 TO	O
its  	its  	 PRP$	O
cell-surface  	cell-surface  	 JJ	B-NP
receptor 	receptor 	 NN	I-NP
.  	.  	 .	O
Discussion  	Discussion  	 NN	O
It  	It  	 PRP	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
proposed  	proposed  	 VBN	O
that  	that  	 IN	O
the  	the  	 DT	O
GAG-binding  	GAG-binding  	 JJ	O
property  	property  	 NN	O
of  	of  	 IN	O
PEDF  	PEDF  	 NNP	B-NP
provides  	provides  	 VBZ	O
the  	the  	 DT	O
molecular  	molecular  	 JJ	B-NP
basis  	basis  	 NN	I-NP
for  	for  	 IN	O
its  	its  	 PRP$	O
association  	association  	 NN	O
with  	with  	 IN	O
extracellular  	extracellular  	 JJ	B-NP
matrices  	matrices  	 NN	I-NP
and  	and  	 CC	O
may  	may  	 MD	O
serve  	serve  	 VB	O
to  	to  	 TO	O
localize  	localize  	 VB	O
PEDF  	PEDF  	 JJ	B-NP
activity  	activity  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
retina  	retina  	 NN	B-NP
and  	and  	 CC	O
CNS  	CNS  	 NNP	B-NP
[  	[  	 -LRB-	O
14  	14  	 CD	O
19  	19  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
present  	present  	 JJ	O
results  	results  	 NNS	O
point  	point  	 VBP	O
to  	to  	 TO	O
direct  	direct  	 JJ	O
effects  	effects  	 NNS	O
these  	these  	 DT	O
polysaccharides  	polysaccharides  	 NN	B-NP
might  	might  	 MD	O
have  	have  	 VB	O
on  	on  	 IN	O
the  	the  	 DT	O
biochemical  	biochemical  	 JJ	B-NP
interactions  	interactions  	 NNS	I-NP
between  	between  	 IN	O
PEDF  	PEDF  	 NNP	B-NP
and  	and  	 CC	O
PEDF  	PEDF  	 NNP	B-NP
receptors  	receptors  	 NNS	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
surfaces  	surfaces  	 NN	O
of  	of  	 IN	O
cells  	cells  	 NNS	O
that  	that  	 WDT	O
respond  	respond  	 VBP	O
to  	to  	 TO	O
this  	this  	 DT	O
neurotrophic  	neurotrophic  	 JJ	B-NP
factor 	factor 	 NN	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
have  	have  	 VBP	O
shown  	shown  	 VBN	O
that  	that  	 IN	O
the  	the  	 DT	O
binding  	binding  	 NN	O
of  	of  	 IN	O
PEDF  	PEDF  	 NNP	B-NP
to  	to  	 TO	O
receptors  	receptors  	 VB	O
in  	in  	 IN	O
retinoblastoma  	retinoblastoma  	 NN	B-NP
cells  	cells  	 NNS	I-NP
is  	is  	 VBZ	O
enhanced  	enhanced  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
extracellular  	extracellular  	 FW	B-NP
heparin 	heparin 	 FW	I-NP
/ 	/ 	 FW	I-NP
HS-like  	HS-like  	 FW	I-NP
GAGs 	GAGs 	 FW	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
can  	can  	 MD	O
be  	be  	 VB	O
found  	found  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
culture  	culture  	 NN	O
medium  	medium  	 NN	O
of  	of  	 IN	O
retinoblastoma  	retinoblastoma  	 NN	B-NP
cells 	cells 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
fact  	fact  	 NN	O
that  	that  	 IN	O
the  	the  	 DT	O
binding  	binding  	 NN	O
of  	of  	 IN	O
PEDF  	PEDF  	 NNP	B-NP
to  	to  	 TO	O
cell  	cell  	 VB	O
surfaces  	surfaces  	 JJ	O
decreases  	decreases  	 NNS	O
with  	with  	 IN	O
heparin 	heparin 	 JJ	B-NP
/ 	/ 	 NNP	I-NP
HS  	HS  	 NNP	I-NP
depletion 	depletion 	 NN	I-NP
,  	,  	 ,	O
implies  	implies  	 VBZ	O
that  	that  	 DT	O
heparin 	heparin 	 JJ	B-NP
/ 	/ 	 NNP	I-NP
HS  	HS  	 NNP	I-NP
molecules  	molecules  	 NNS	I-NP
might  	might  	 MD	O
act  	act  	 VB	O
as  	as  	 IN	O
cofactors  	cofactors  	 NN	B-NP
for  	for  	 IN	I-NP
PEDF-receptor  	PEDF-receptor  	 JJ	I-NP
interactions 	interactions 	 NNS	I-NP
.  	.  	 .	O
Interactions  	Interactions  	 NNS	B-NP
between  	between  	 IN	O
PEDF  	PEDF  	 NNP	B-NP
and  	and  	 CC	O
extracellular  	extracellular  	 JJ	B-NP
GAGs  	GAGs  	 NN	I-NP
can  	can  	 MD	O
also  	also  	 RB	O
explain  	explain  	 VB	O
the  	the  	 DT	O
complex  	complex  	 NN	O
formed  	formed  	 VBN	O
by  	by  	 IN	O
PEDF  	PEDF  	 NNP	B-NP
with  	with  	 IN	O
CM  	CM  	 NNP	O
even  	even  	 RB	O
after  	after  	 IN	O
protease  	protease  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
latter 	latter 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
PEDF-heparin 	PEDF-heparin 	 JJ	B-NP
/ 	/ 	 NNP	I-NP
HS  	HS  	 NNP	I-NP
complex  	complex  	 NN	O
may  	may  	 MD	O
somehow  	somehow  	 RB	O
facilitate  	facilitate  	 VB	O
encounters  	encounters  	 VBN	O
between  	between  	 IN	O
PEDF  	PEDF  	 NNP	B-NP
and  	and  	 CC	O
its  	its  	 PRP$	O
receptor 	receptor 	 NN	B-NP
,  	,  	 ,	O
e.g.  	e.g.  	 NNP	O
,  	,  	 ,	O
by  	by  	 IN	O
inducing  	inducing  	 VBG	O
a  	a  	 DT	O
conformational  	conformational  	 JJ	B-NP
change  	change  	 NN	I-NP
in  	in  	 IN	O
PEDF 	PEDF 	 NNP	B-NP
,  	,  	 ,	O
which  	which  	 WDT	O
might  	might  	 MD	O
accelerate  	accelerate  	 VB	O
the  	the  	 DT	O
ligand-receptor  	ligand-receptor  	 JJ	B-NP
interactions 	interactions 	 NNS	I-NP
.  	.  	 .	O
In  	In  	 IN	O
addition 	addition 	 NN	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
receptor  	receptor  	 NN	B-NP
may  	may  	 MD	O
also  	also  	 RB	O
form  	form  	 VB	O
a  	a  	 DT	O
complex  	complex  	 NN	O
with  	with  	 IN	O
heparin 	heparin 	 JJ	O
/ 	/ 	 NNP	O
HS  	HS  	 NNP	O
to  	to  	 TO	O
facilitate  	facilitate  	 VB	O
interactions  	interactions  	 VBN	B-NP
with  	with  	 IN	O
the  	the  	 DT	O
ligand 	ligand 	 NN	B-NP
.  	.  	 .	O
To  	To  	 TO	O
our  	our  	 PRP$	O
knowledge 	knowledge 	 NN	O
,  	,  	 ,	O
this  	this  	 DT	O
is  	is  	 VBZ	O
the  	the  	 DT	O
first  	first  	 JJ	O
report  	report  	 NN	O
on  	on  	 IN	O
the  	the  	 DT	O
production  	production  	 NN	O
of  	of  	 IN	O
GAGs  	GAGs  	 JJ	O
by  	by  	 IN	O
retinoblastoma  	retinoblastoma  	 NN	B-NP
cells 	cells 	 NNS	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
found  	found  	 VBD	O
that  	that  	 IN	O
these  	these  	 DT	O
cells  	cells  	 NNS	O
produce  	produce  	 VBP	O
HS 	HS 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
heparin  	heparin  	 VBD	I-NP
secreted  	secreted  	 VBN	O
into  	into  	 IN	O
the  	the  	 DT	O
culturing  	culturing  	 JJ	B-NP
media 	media 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
retina  	retina  	 NN	B-NP
and  	and  	 CC	O
malignant  	malignant  	 JJ	B-NP
solid  	solid  	 JJ	I-NP
tumors  	tumors  	 NNS	I-NP
also  	also  	 RB	O
produce  	produce  	 VB	O
the  	the  	 DT	O
sulfated  	sulfated  	 JJ	B-NP
GAGs  	GAGs  	 NN	I-NP
[  	[  	 -LRB-	O
1  	1  	 CD	O
2  	2  	 CD	O
22  	22  	 CD	O
23  	23  	 CD	O
24  	24  	 CD	O
25  	25  	 CD	O
26  	26  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Although  	Although  	 IN	O
HSs  	HSs  	 NNS	B-NP
are  	are  	 VBP	O
mostly  	mostly  	 RB	O
found  	found  	 VBN	O
as  	as  	 IN	O
proteoglycans  	proteoglycans  	 VBG	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
basal  	basal  	 JJ	B-NP
lamina  	lamina  	 NN	I-NP
or  	or  	 CC	O
the  	the  	 DT	O
plasma  	plasma  	 JJ	B-NP
membrane 	membrane 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
HSs  	HSs  	 JJ	O
in  	in  	 IN	O
the  	the  	 DT	O
culturing  	culturing  	 JJ	B-NP
medium  	medium  	 NN	I-NP
might  	might  	 MD	O
be  	be  	 VB	O
a  	a  	 DT	O
result  	result  	 NN	O
of  	of  	 IN	O
shedding  	shedding  	 VBG	O
or  	or  	 CC	O
release  	release  	 NN	O
of  	of  	 IN	O
their  	their  	 PRP$	O
extracellular  	extracellular  	 JJ	B-NP
domains  	domains  	 NN	I-NP
from  	from  	 IN	O
the  	the  	 DT	O
cell  	cell  	 NN	O
membranes  	membranes  	 NN	O
as  	as  	 IN	O
soluble  	soluble  	 JJ	B-NP
components 	components 	 NNS	I-NP
.  	.  	 .	O
Cell-associated  	Cell-associated  	 NNP	O
HS  	HS  	 NNP	B-NP
proteoglycans  	proteoglycans  	 NN	I-NP
can  	can  	 MD	O
undergo  	undergo  	 VB	O
regulated  	regulated  	 VBN	O
shedding  	shedding  	 VBG	O
from  	from  	 IN	O
the  	the  	 DT	O
membrane  	membrane  	 NN	O
into  	into  	 IN	O
the  	the  	 DT	O
soluble  	soluble  	 JJ	B-NP
extracellular  	extracellular  	 JJ	I-NP
matrix  	matrix  	 NN	I-NP
or  	or  	 CC	O
culturing  	culturing  	 JJ	B-NP
medium  	medium  	 NN	I-NP
converting  	converting  	 VBG	O
the  	the  	 DT	O
membrane  	membrane  	 JJ	O
anchored  	anchored  	 JJ	O
molecules  	molecules  	 NNS	O
into  	into  	 IN	O
soluble  	soluble  	 JJ	B-NP
effectors  	effectors  	 NNS	I-NP
[  	[  	 -LRB-	O
1  	1  	 CD	O
2  	2  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
conditioned  	conditioned  	 JJ	O
media  	media  	 NNS	O
of  	of  	 IN	O
all  	all  	 PDT	O
the  	the  	 DT	O
tested  	tested  	 JJ	O
batches  	batches  	 NNS	O
of  	of  	 IN	O
retinoblastoma  	retinoblastoma  	 NN	B-NP
cells 	cells 	 NNS	I-NP
,  	,  	 ,	O
we  	we  	 PRP	O
detected  	detected  	 VBD	O
heparin  	heparin  	 JJ	O
and  	and  	 CC	O
HS  	HS  	 NNP	B-NP
with  	with  	 IN	O
binding  	binding  	 JJ	O
affinity  	affinity  	 NN	B-NP
for  	for  	 IN	I-NP
PEDF 	PEDF 	 NNP	I-NP
.  	.  	 .	O
The  	The  	 DT	O
estimated  	estimated  	 JJ	O
concentrations  	concentrations  	 NNS	B-NP
of  	of  	 IN	O
these  	these  	 DT	O
GAGs  	GAGs  	 JJ	O
in  	in  	 IN	O
the  	the  	 DT	O
media  	media  	 NNS	O
may  	may  	 MD	O
vary  	vary  	 VB	O
with  	with  	 IN	O
cell  	cell  	 NN	O
density  	density  	 NN	O
and  	and  	 CC	O
conditioning  	conditioning  	 JJ	O
time 	time 	 NN	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
under  	under  	 IN	O
the  	the  	 DT	O
conditions  	conditions  	 NNS	O
used 	used 	 VBN	O
,  	,  	 ,	O
they  	they  	 PRP	O
were  	were  	 VBD	O
within  	within  	 IN	O
the  	the  	 DT	O
linear  	linear  	 JJ	B-NP
range  	range  	 NN	I-NP
of  	of  	 IN	I-NP
HS-PEDF  	HS-PEDF  	 JJ	I-NP
complex  	complex  	 JJ	O
formation  	formation  	 NN	O
(  	(  	 -LRB-	O
EC  	EC  	 NNP	B-NP
50  	50  	 CD	O
=  	=  	 SYM	O
40  	40  	 CD	O
μg 	μg 	 CD	B-NP
/ 	/ 	 CD	I-NP
ml 	ml 	 CD	I-NP
)  	)  	 -RRB-	O
[  	[  	 -LRB-	O
14  	14  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
fact  	fact  	 NN	O
that  	that  	 IN	O
depletion  	depletion  	 NN	O
of  	of  	 IN	O
heparin 	heparin 	 CD	B-NP
/ 	/ 	 CD	I-NP
HS-like  	HS-like  	 JJ	I-NP
GAGs  	GAGs  	 NN	I-NP
from  	from  	 IN	O
the  	the  	 DT	O
culturing  	culturing  	 JJ	B-NP
media  	media  	 NNS	I-NP
results  	results  	 NNS	I-NP
in  	in  	 IN	O
inhibition  	inhibition  	 NN	O
of  	of  	 IN	O
PEDF  	PEDF  	 NNP	B-NP
binding  	binding  	 VBD	O
to  	to  	 TO	O
cell  	cell  	 NN	B-NP
surface  	surface  	 NN	I-NP
receptors  	receptors  	 NN	I-NP
points  	points  	 NNS	O
to  	to  	 TO	O
functional  	functional  	 VB	B-NP
roles  	roles  	 NNS	I-NP
for  	for  	 IN	O
these  	these  	 DT	O
GAGs  	GAGs  	 JJ	O
such  	such  	 JJ	O
as  	as  	 IN	O
those  	those  	 DT	O
of  	of  	 IN	O
positive  	positive  	 JJ	B-NP
modulators  	modulators  	 NN	I-NP
of  	of  	 IN	I-NP
PEDF-receptor  	PEDF-receptor  	 JJ	I-NP
interactions 	interactions 	 NNS	I-NP
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
regard 	regard 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
observed  	observed  	 VBD	O
that  	that  	 DT	O
depletion  	depletion  	 NN	O
from  	from  	 IN	O
the  	the  	 DT	O
Y-79  	Y-79  	 JJ	B-NP
cell  	cell  	 NN	I-NP
cultures  	cultures  	 NNS	I-NP
of  	of  	 IN	I-NP
heparin  	heparin  	 NN	I-NP
with  	with  	 IN	O
heparinase  	heparinase  	 NN	B-NP
was  	was  	 VBD	O
lower  	lower  	 JJR	O
than  	than  	 IN	O
those  	those  	 DT	O
depleted  	depleted  	 NN	O
of  	of  	 IN	O
HS  	HS  	 NNP	B-NP
with  	with  	 IN	O
heparitinase 	heparitinase 	 NN	B-NP
,  	,  	 ,	O
suggesting  	suggesting  	 VBG	O
that  	that  	 IN	O
the  	the  	 DT	O
retinoblastoma-derived  	retinoblastoma-derived  	 JJ	B-NP
HS  	HS  	 NNP	I-NP
was  	was  	 VBD	O
more  	more  	 RBR	O
effective  	effective  	 JJ	O
than  	than  	 IN	O
the  	the  	 DT	O
retinoblastoma-derived  	retinoblastoma-derived  	 JJ	B-NP
heparin 	heparin 	 NN	I-NP
.  	.  	 .	O
This  	This  	 DT	O
observation  	observation  	 NN	O
can  	can  	 MD	O
be  	be  	 VB	O
explained  	explained  	 VBN	O
by  	by  	 IN	O
structural 	structural 	 JJ	O
,  	,  	 ,	O
compositional  	compositional  	 NN	B-NP
and  	and  	 CC	O
functional  	functional  	 JJ	B-NP
differences  	differences  	 NNS	I-NP
between  	between  	 IN	O
heparin  	heparin  	 NN	B-NP
and  	and  	 CC	O
HS  	HS  	 NNP	B-NP
GAGs 	GAGs 	 NNP	I-NP
.  	.  	 .	O
GAG-binding  	GAG-binding  	 JJ	O
proteins  	proteins  	 NNS	O
can  	can  	 MD	O
be  	be  	 VB	O
differentially  	differentially  	 JJ	O
sensitive  	sensitive  	 JJ	O
to  	to  	 TO	O
variations  	variations  	 NNS	O
in  	in  	 IN	O
GAG  	GAG  	 NNP	O
structure  	structure  	 NN	O
[  	[  	 -LRB-	O
27  	27  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
GAGs  	GAGs  	 NNP	O
produced  	produced  	 VBD	O
among  	among  	 IN	O
different  	different  	 JJ	O
cell  	cell  	 NN	O
types  	types  	 NNS	O
have  	have  	 VBP	O
structural  	structural  	 JJ	O
and  	and  	 CC	O
compositional  	compositional  	 JJ	B-NP
differences  	differences  	 NNS	I-NP
and  	and  	 CC	O
structural  	structural  	 JJ	B-NP
changes  	changes  	 NNS	I-NP
in  	in  	 IN	O
GAGs  	GAGs  	 NNS	O
are  	are  	 VBP	O
known  	known  	 VBN	O
to  	to  	 TO	O
occur  	occur  	 VB	O
in  	in  	 IN	O
cells  	cells  	 NNS	O
undergoing  	undergoing  	 VBG	O
morphological  	morphological  	 JJ	B-NP
differentiation  	differentiation  	 NN	I-NP
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
malignant  	malignant  	 JJ	B-NP
transformations  	transformations  	 NNS	I-NP
[  	[  	 -LRB-	O
28  	28  	 CD	O
29  	29  	 CD	O
30  	30  	 CD	O
31  	31  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Thus 	Thus 	 RB	O
,  	,  	 ,	O
in  	in  	 IN	O
the  	the  	 DT	O
native  	native  	 JJ	O
retina 	retina 	 NN	B-NP
,  	,  	 ,	O
or  	or  	 CC	O
other  	other  	 JJ	O
tissue 	tissue 	 NN	O
,  	,  	 ,	O
modulation  	modulation  	 VBG	O
of  	of  	 IN	O
the  	the  	 DT	O
PEDF-receptor  	PEDF-receptor  	 JJ	B-NP
interactions  	interactions  	 NNS	I-NP
may  	may  	 MD	O
depend  	depend  	 VB	O
on  	on  	 IN	O
the  	the  	 DT	O
expression  	expression  	 NN	O
of  	of  	 IN	O
GAGs 	GAGs 	 NNP	O
,  	,  	 ,	O
which  	which  	 WDT	O
occur  	occur  	 VBP	O
during  	during  	 IN	O
development  	development  	 NN	O
and  	and  	 CC	O
pathological  	pathological  	 JJ	B-NP
conditions 	conditions 	 NNS	I-NP
.  	.  	 .	O
Our  	Our  	 PRP$	O
data  	data  	 NNS	O
offer  	offer  	 VBP	O
interesting  	interesting  	 JJ	O
possibilities  	possibilities  	 NNS	O
of  	of  	 IN	O
regulation  	regulation  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
activity  	activity  	 NN	O
of  	of  	 IN	O
PEDF 	PEDF 	 NNP	B-NP
.  	.  	 .	O
The  	The  	 DT	O
ratio  	ratio  	 NN	O
and  	and  	 CC	O
amount  	amount  	 NN	O
of  	of  	 IN	O
production  	production  	 NN	O
of  	of  	 IN	O
heparin  	heparin  	 NN	B-NP
and  	and  	 CC	O
HS  	HS  	 NNP	B-NP
by  	by  	 IN	O
cells  	cells  	 NNS	O
bearing  	bearing  	 VBG	B-NP
PEDF  	PEDF  	 NNP	I-NP
receptors  	receptors  	 NNS	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
an  	an  	 DT	O
important  	important  	 JJ	O
mechanism  	mechanism  	 NN	O
to  	to  	 TO	O
control  	control  	 VB	O
the  	the  	 DT	O
activity  	activity  	 NN	O
of  	of  	 IN	O
PEDF  	PEDF  	 NNP	B-NP
as  	as  	 RB	O
is  	is  	 VBZ	O
the  	the  	 DT	O
modulation  	modulation  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
rate  	rate  	 NN	O
of  	of  	 IN	O
expression  	expression  	 NN	O
of  	of  	 IN	O
PEDF  	PEDF  	 NNP	B-NP
receptors 	receptors 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
data  	data  	 NNS	O
obtained  	obtained  	 VBD	O
so  	so  	 RB	O
far  	far  	 RB	O
on  	on  	 IN	O
the  	the  	 DT	O
action  	action  	 NN	O
of  	of  	 IN	O
PEDF  	PEDF  	 NNP	B-NP
on  	on  	 IN	O
different  	different  	 JJ	O
cells  	cells  	 NNS	O
may  	may  	 MD	O
have  	have  	 VB	O
not  	not  	 RB	O
considered  	considered  	 VBN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
these  	these  	 DT	O
cofactors  	cofactors  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
media 	media 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
binding  	binding  	 NN	O
of  	of  	 IN	O
GAGs  	GAGs  	 JJ	O
to  	to  	 TO	O
PEDF  	PEDF  	 NNP	B-NP
that  	that  	 WDT	O
modulate  	modulate  	 VBP	O
the  	the  	 DT	O
binding  	binding  	 NN	O
of  	of  	 IN	O
these  	these  	 DT	O
factors  	factors  	 NNS	O
to  	to  	 TO	O
its  	its  	 PRP$	O
receptor  	receptor  	 NN	B-NP
opens  	opens  	 VBZ	O
also  	also  	 RB	O
the  	the  	 DT	O
possibility  	possibility  	 NN	O
that  	that  	 IN	O
different  	different  	 JJ	O
GAGs  	GAGs  	 NN	O
may  	may  	 MD	O
modulate  	modulate  	 VB	O
differently  	differently  	 RB	O
the  	the  	 DT	O
affinity  	affinity  	 NN	B-NP
of  	of  	 IN	I-NP
PEDF  	PEDF  	 NNP	I-NP
for  	for  	 IN	O
its  	its  	 PRP$	O
receptors 	receptors 	 NNS	B-NP
,  	,  	 ,	O
by  	by  	 IN	O
increasing  	increasing  	 VBG	O
or  	or  	 CC	O
even  	even  	 RB	O
decreasing  	decreasing  	 VBG	O
it  	it  	 PRP	O
in  	in  	 IN	O
some  	some  	 DT	O
cases 	cases 	 NNS	O
.  	.  	 .	O
Finally 	Finally 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
fact  	fact  	 NN	O
that  	that  	 IN	O
the  	the  	 DT	O
GAG  	GAG  	 NNP	O
and  	and  	 CC	O
receptor  	receptor  	 JJ	B-NP
binding  	binding  	 JJ	I-NP
regions  	regions  	 NNS	I-NP
are  	are  	 VBP	O
on  	on  	 IN	O
opposite  	opposite  	 JJ	O
regions  	regions  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
PEDF  	PEDF  	 NNP	B-NP
molecule 	molecule 	 NN	I-NP
,  	,  	 ,	O
suggest  	suggest  	 VBP	O
the  	the  	 DT	O
possibility  	possibility  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
existence  	existence  	 NN	O
of  	of  	 IN	O
PEDF  	PEDF  	 NNP	B-NP
mutants  	mutants  	 NN	I-NP
or  	or  	 CC	O
engineered  	engineered  	 JJ	O
variants  	variants  	 NN	O
that 	that 	 IN	O
,  	,  	 ,	O
having  	having  	 VBG	O
lost  	lost  	 VBN	O
or  	or  	 CC	O
decreased  	decreased  	 VBD	O
GAG-binding  	GAG-binding  	 JJ	O
capabilities 	capabilities 	 NNS	O
,  	,  	 ,	O
still  	still  	 RB	O
show  	show  	 VB	O
high  	high  	 JJ	O
affinity  	affinity  	 NN	B-NP
for  	for  	 IN	I-NP
the  	the  	 DT	I-NP
PEDF  	PEDF  	 NNP	I-NP
receptor  	receptor  	 NN	I-NP
in  	in  	 IN	O
a  	a  	 DT	O
way  	way  	 NN	O
not  	not  	 RB	O
dependent  	dependent  	 JJ	O
upon  	upon  	 IN	O
GAGs  	GAGs  	 JJ	O
content  	content  	 NN	O
or  	or  	 CC	O
composition 	composition 	 NN	O
.  	.  	 .	O
These  	These  	 DT	O
possibilities  	possibilities  	 NNS	O
are  	are  	 VBP	O
discussed  	discussed  	 VBN	O
under  	under  	 IN	O
the  	the  	 DT	O
consideration  	consideration  	 NN	B-NP
that  	that  	 IN	O
some  	some  	 DT	O
of  	of  	 IN	O
them  	them  	 PRP	O
may  	may  	 MD	O
have  	have  	 VB	O
important  	important  	 JJ	O
implications  	implications  	 NNS	B-NP
if  	if  	 IN	O
PEDF 	PEDF 	 NNP	B-NP
,  	,  	 ,	O
or  	or  	 CC	O
molecules  	molecules  	 NNS	O
derived  	derived  	 VBN	O
from  	from  	 IN	O
it 	it 	 PRP	O
,  	,  	 ,	O
are  	are  	 VBP	O
to  	to  	 TO	O
be  	be  	 VB	O
used  	used  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
future  	future  	 NN	O
as  	as  	 IN	O
therapeutic  	therapeutic  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
primary  	primary  	 JJ	B-NP
consequence  	consequence  	 NN	I-NP
of  	of  	 IN	O
reducing  	reducing  	 VBG	O
the  	the  	 DT	O
heparin 	heparin 	 JJ	O
/ 	/ 	 NNP	O
HS  	HS  	 NNP	O
and  	and  	 CC	O
its  	its  	 PRP$	O
sulfation  	sulfation  	 NN	B-NP
was  	was  	 VBD	O
to  	to  	 TO	O
minimize  	minimize  	 VB	O
a  	a  	 DT	O
binding  	binding  	 JJ	O
site  	site  	 NN	O
required  	required  	 VBN	O
for  	for  	 IN	O
PEDF  	PEDF  	 NNP	B-NP
activity 	activity 	 NN	I-NP
.  	.  	 .	O
Although  	Although  	 IN	O
GAGs  	GAGs  	 JJ	O
store  	store  	 NN	B-NP
PEDF  	PEDF  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
extracellular  	extracellular  	 JJ	B-NP
matrix  	matrix  	 NNS	I-NP
[  	[  	 -LRB-	O
14  	14  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
a  	a  	 DT	O
more  	more  	 RBR	O
direct  	direct  	 JJ	O
mechanism  	mechanism  	 NN	O
appears  	appears  	 VBZ	O
necessary 	necessary 	 JJ	O
,  	,  	 ,	O
namely 	namely 	 RB	O
,  	,  	 ,	O
its  	its  	 PRP$	O
participation  	participation  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
binding  	binding  	 NN	O
of  	of  	 IN	O
PEDF  	PEDF  	 NNP	B-NP
to  	to  	 TO	O
its  	its  	 PRP$	O
receptor 	receptor 	 NN	B-NP
.  	.  	 .	O
In  	In  	 IN	O
a  	a  	 DT	O
spatial  	spatial  	 JJ	B-NP
structure  	structure  	 NN	I-NP
of  	of  	 IN	I-NP
PEDF 	PEDF 	 NNP	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
heparin 	heparin 	 JJ	B-NP
/ 	/ 	 NNP	I-NP
HS  	HS  	 NNP	I-NP
binding  	binding  	 JJ	I-NP
domain  	domain  	 NN	I-NP
of  	of  	 IN	I-NP
PEDF  	PEDF  	 NNP	I-NP
maps  	maps  	 NNS	I-NP
to  	to  	 TO	O
the  	the  	 DT	O
opposite  	opposite  	 JJ	O
side  	side  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
neurotrophic  	neurotrophic  	 JJ	O
active  	active  	 JJ	O
region  	region  	 NN	O
[  	[  	 -LRB-	O
20  	20  	 CD	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
allowing  	allowing  	 VBG	O
distinct  	distinct  	 JJ	O
and  	and  	 CC	O
non-overlapping  	non-overlapping  	 JJ	B-NP
interactions  	interactions  	 NNS	I-NP
with  	with  	 IN	O
heparin 	heparin 	 JJ	O
/ 	/ 	 NNP	O
HS  	HS  	 NNP	O
on  	on  	 IN	O
one  	one  	 CD	O
side  	side  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
protein 	protein 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
with  	with  	 IN	O
the  	the  	 DT	O
neurotrophic  	neurotrophic  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
on  	on  	 IN	O
its  	its  	 PRP$	O
opposite  	opposite  	 JJ	O
side 	side 	 NN	O
.  	.  	 .	O
Our  	Our  	 PRP$	O
data  	data  	 NNS	O
suggest  	suggest  	 VBP	O
that  	that  	 IN	O
the  	the  	 DT	O
intrinsic  	intrinsic  	 JJ	B-NP
affinity  	affinity  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
cell  	cell  	 NN	I-NP
surface  	surface  	 NN	I-NP
receptor  	receptor  	 NN	I-NP
for  	for  	 IN	I-NP
PEDF  	PEDF  	 NNP	I-NP
appears  	appears  	 VBZ	O
low 	low 	 JJ	O
,  	,  	 ,	O
whereas  	whereas  	 IN	O
the  	the  	 DT	O
heparin 	heparin 	 JJ	B-NP
/ 	/ 	 CD	I-NP
HS-PEDF  	HS-PEDF  	 JJ	I-NP
complex  	complex  	 NN	I-NP
is  	is  	 VBZ	O
recognized  	recognized  	 VBN	O
with  	with  	 IN	O
high  	high  	 JJ	O
affinity 	affinity 	 NN	B-NP
.  	.  	 .	O
In  	In  	 IN	O
addition 	addition 	 NN	B-NP
,  	,  	 ,	O
a  	a  	 DT	O
direct  	direct  	 JJ	O
interaction  	interaction  	 NN	O
between  	between  	 IN	O
the  	the  	 DT	O
receptor  	receptor  	 NN	B-NP
and  	and  	 CC	O
GAGs  	GAGs  	 NNP	O
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
necessary 	necessary 	 JJ	O
.  	.  	 .	O
Although  	Although  	 IN	O
details  	details  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
mechanism  	mechanism  	 NN	O
remain  	remain  	 VBP	O
to  	to  	 TO	O
be  	be  	 VB	O
revealed 	revealed 	 VBN	O
,  	,  	 ,	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
clear  	clear  	 JJ	O
that  	that  	 IN	O
heparin 	heparin 	 JJ	O
/ 	/ 	 NNP	O
HS  	HS  	 NNP	O
is  	is  	 VBZ	O
required  	required  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
first  	first  	 JJ	O
step  	step  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
neurotrophic  	neurotrophic  	 JJ	B-NP
activity  	activity  	 NN	I-NP
of  	of  	 IN	I-NP
PEDF 	PEDF 	 NNP	I-NP
,  	,  	 ,	O
namely  	namely  	 RB	O
the  	the  	 DT	O
encounters  	encounters  	 NN	O
with  	with  	 IN	O
its  	its  	 PRP$	O
receptor  	receptor  	 NN	B-NP
at  	at  	 IN	O
the  	the  	 DT	O
cell  	cell  	 NN	O
surface 	surface 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
differentiation  	differentiation  	 NN	B-NP
and  	and  	 CC	O
survival  	survival  	 NN	O
of  	of  	 IN	O
cells  	cells  	 NNS	O
in  	in  	 IN	O
vivo  	vivo  	 NNS	B-NP
may  	may  	 MD	O
be  	be  	 VB	O
regulated  	regulated  	 VBN	O
not  	not  	 RB	O
only  	only  	 RB	O
by  	by  	 IN	O
the  	the  	 DT	O
expression  	expression  	 NN	O
of  	of  	 IN	O
PEDF  	PEDF  	 NNP	B-NP
and  	and  	 CC	O
its  	its  	 PRP$	O
receptor  	receptor  	 NN	B-NP
but  	but  	 CC	O
also  	also  	 RB	O
by  	by  	 IN	O
the  	the  	 DT	O
temporal  	temporal  	 NN	O
and  	and  	 CC	O
spatial  	spatial  	 JJ	B-NP
expression  	expression  	 NN	I-NP
of  	of  	 IN	O
GAGs 	GAGs 	 JJ	O
.  	.  	 .	O
Methods  	Methods  	 NNP	O
Materials  	Materials  	 NNPS	O
Heparin  	Heparin  	 NNP	B-NP
purified  	purified  	 NN	I-NP
from  	from  	 IN	O
bovine  	bovine  	 JJ	B-NP
intestinal  	intestinal  	 JJ	I-NP
mucosa 	mucosa 	 NN	I-NP
,  	,  	 ,	O
chondroitin  	chondroitin  	 FW	B-NP
sulfates  	sulfates  	 FW	I-NP
A 	A 	 NNP	O
,  	,  	 ,	O
B  	B  	 NNP	O
and  	and  	 CC	O
C 	C 	 NNP	O
,  	,  	 ,	O
chondroitinase  	chondroitinase  	 VBG	O
ABC 	ABC 	 NNP	B-NP
,  	,  	 ,	O
sodium  	sodium  	 JJ	B-NP
chlorate 	chlorate 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
Toluidine  	Toluidine  	 NNP	B-NP
Blue-O  	Blue-O  	 NNP	I-NP
were  	were  	 VBD	O
purchased  	purchased  	 VBN	O
from  	from  	 IN	O
Sigma 	Sigma 	 NNP	B-NP
.  	.  	 .	O
Subtilisin  	Subtilisin  	 NNP	B-NP
was  	was  	 VBD	O
from  	from  	 IN	O
Boehringer  	Boehringer  	 NNP	O
Mannheim 	Mannheim 	 NNP	O
.  	.  	 .	O
Heparitinase  	Heparitinase  	 NNP	B-NP
( 	( 	 -LRB-	O
E.C.4.2.2.8 	E.C.4.2.2.8 	 NNP	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
heparinase  	heparinase  	 NNS	B-NP
( 	( 	 -LRB-	O
E.C.4.2.2.7 	E.C.4.2.2.7 	 NNP	O
)  	)  	 -RRB-	O
purified  	purified  	 NN	O
from  	from  	 IN	O
Flavobacterium  	Flavobacterium  	 NNP	B-NP
heparinum  	heparinum  	 NN	I-NP
were  	were  	 VBD	O
from  	from  	 IN	O
ICN  	ICN  	 NNP	B-NP
Biomedicals 	Biomedicals 	 NNP	O
,  	,  	 ,	O
Inc.  	Inc.  	 NNP	O
and  	and  	 CC	O
alternatively  	alternatively  	 RB	O
from  	from  	 IN	O
Seikagaku 	Seikagaku 	 NNP	B-NP
.  	.  	 .	O
Heparan  	Heparan  	 JJ	B-NP
sulfate  	sulfate  	 NNS	I-NP
( 	( 	 -LRB-	O
HS 	HS 	 NNP	B-NP
)  	)  	 -RRB-	O
purified  	purified  	 NN	O
from  	from  	 IN	O
bovine  	bovine  	 JJ	B-NP
kidney  	kidney  	 NN	I-NP
was  	was  	 VBD	O
from  	from  	 IN	O
Seikagaku 	Seikagaku 	 NNP	B-NP
,  	,  	 ,	O
hyaluronidase  	hyaluronidase  	 NNS	B-NP
( 	( 	 -LRB-	O
E.C.4.2.2.1 	E.C.4.2.2.1 	 NNP	O
)  	)  	 -RRB-	O
purified  	purified  	 NN	O
from  	from  	 IN	O
Streptomyces  	Streptomyces  	 NNP	B-NP
hyalurolyticus  	hyalurolyticus  	 NN	I-NP
from  	from  	 IN	O
ICN  	ICN  	 NNP	B-NP
Pharmaceuticals 	Pharmaceuticals 	 NNP	O
,  	,  	 ,	O
Coomassie  	Coomassie  	 NNP	B-NP
Brilliant  	Brilliant  	 NNP	I-NP
Blue  	Blue  	 NNP	I-NP
from  	from  	 IN	O
BioRad 	BioRad 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
Q-Sepharose  	Q-Sepharose  	 JJ	B-NP
from  	from  	 IN	O
Pharmacia 	Pharmacia 	 NNP	B-NP
.  	.  	 .	O
Recombinant  	Recombinant  	 NNP	B-NP
PEDF  	PEDF  	 NNP	I-NP
was  	was  	 VBD	O
purified  	purified  	 VBN	O
from  	from  	 IN	O
BHK  	BHK  	 NNP	B-NP
cells  	cells  	 NNS	O
containing  	containing  	 VBG	O
an  	an  	 DT	O
expression  	expression  	 NN	B-NP
vector  	vector  	 NN	I-NP
with  	with  	 IN	O
human  	human  	 JJ	O
PEDF  	PEDF  	 NNP	B-NP
cDNA 	cDNA 	 NNP	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
previously  	previously  	 RB	O
described  	described  	 VBN	O
[  	[  	 -LRB-	O
19  	19  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Preparation  	Preparation  	 NN	B-NP
of  	of  	 IN	O
conditioned  	conditioned  	 JJ	O
media  	media  	 NNS	O
Human  	Human  	 JJ	B-NP
retinoblastoma  	retinoblastoma  	 NN	I-NP
Y-79  	Y-79  	 CD	I-NP
cells  	cells  	 NNS	I-NP
( 	( 	 -LRB-	O
0.45-5  	0.45-5  	 CD	O
×  	×  	 CD	O
10  	10  	 CD	O
6cells 	6cells 	 CD	O
/ 	/ 	 CD	O
ml 	ml 	 CD	O
)  	)  	 -RRB-	O
were  	were  	 VBD	O
cultured  	cultured  	 VBN	O
in  	in  	 IN	O
defined  	defined  	 JJ	O
media  	media  	 NNS	O
( 	( 	 -LRB-	O
MEM  	MEM  	 NNP	B-NP
containing  	containing  	 VBG	O
10  	10  	 CD	O
mM  	mM  	 JJ	B-NP
HEPES 	HEPES 	 NNP	I-NP
,  	,  	 ,	O
1  	1  	 CD	O
mM  	mM  	 JJ	B-NP
Na-pyruvate 	Na-pyruvate 	 NN	I-NP
,  	,  	 ,	O
0.1  	0.1  	 CD	O
mM  	mM  	 JJ	B-NP
non-essential  	non-essential  	 JJ	I-NP
amino  	amino  	 JJ	I-NP
acids 	acids 	 NNS	I-NP
,  	,  	 ,	O
1  	1  	 CD	O
mM  	mM  	 JJ	B-NP
L-glutamine 	L-glutamine 	 NN	I-NP
,  	,  	 ,	O
1 	1 	 CD	O
%  	%  	 NN	O
penicillin 	penicillin 	 FW	B-NP
/ 	/ 	 FW	I-NP
streptomycin  	streptomycin  	 FW	I-NP
( 	( 	 -LRB-	O
LifeTechnologies 	LifeTechnologies 	 NNP	B-NP
) 	) 	 -RRB-	O
)  	)  	 -RRB-	O
at  	at  	 IN	O
37°C  	37°C  	 CD	O
for  	for  	 IN	O
16-24  	16-24  	 CD	O
h 	h 	 NNS	B-NP
.  	.  	 .	I-NP
Media  	Media  	 NNS	I-NP
exposed  	exposed  	 VBN	O
to  	to  	 TO	O
these  	these  	 DT	O
conditions  	conditions  	 NNS	O
is  	is  	 VBZ	O
referred  	referred  	 VBN	O
as  	as  	 IN	O
CM 	CM 	 NNP	O
.  	.  	 .	O
CM  	CM  	 NNP	O
was  	was  	 VBD	O
separated  	separated  	 VBN	O
from  	from  	 IN	O
cells  	cells  	 NNS	O
by  	by  	 IN	O
centrifugation  	centrifugation  	 NNS	B-NP
( 	( 	 -LRB-	O
1000  	1000  	 CD	O
×  	×  	 CD	O
g  	g  	 NN	O
for  	for  	 IN	O
5  	5  	 CD	O
min  	min  	 NN	B-NP
at  	at  	 IN	O
4°C 	4°C 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
concentrated  	concentrated  	 VBN	O
by  	by  	 IN	O
ultrafiltration  	ultrafiltration  	 NNS	B-NP
using  	using  	 VBG	O
membrane  	membrane  	 JJ	B-NP
filters  	filters  	 NNS	I-NP
with  	with  	 IN	O
MWCO  	MWCO  	 NNP	B-NP
=  	=  	 SYM	O
10,000  	10,000  	 CD	O
( 	( 	 -LRB-	O
Amicon  	Amicon  	 NNP	B-NP
YM10  	YM10  	 NNP	I-NP
filters 	filters 	 NNS	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
GAGs 	GAGs 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
polyanions  	polyanions  	 NN	I-NP
purification  	purification  	 NNS	I-NP
was  	was  	 VBD	O
performed  	performed  	 VBN	O
as  	as  	 RB	O
follows 	follows 	 VBZ	O
:  	:  	 :	O
concentrated  	concentrated  	 VBD	O
CM  	CM  	 NNP	O
( 	( 	 -LRB-	O
15  	15  	 CD	O
ml 	ml 	 CD	O
)  	)  	 -RRB-	O
was  	was  	 VBD	O
dialyzed  	dialyzed  	 VBN	O
against  	against  	 IN	O
buffer  	buffer  	 JJ	B-NP
Q  	Q  	 NNP	I-NP
( 	( 	 -LRB-	O
50  	50  	 CD	O
mM  	mM  	 JJ	B-NP
Tris-HCl 	Tris-HCl 	 NN	I-NP
,  	,  	 ,	O
pH  	pH  	 NNP	B-NP
8.0 	8.0 	 NNP	O
,  	,  	 ,	O
0.2  	0.2  	 CD	O
M  	M  	 NNP	O
NaCl 	NaCl 	 NNP	B-NP
,  	,  	 ,	O
6  	6  	 CD	O
M  	M  	 NNP	O
Urea 	Urea 	 NNP	B-NP
,  	,  	 ,	O
0.5 	0.5 	 CD	O
%  	%  	 NN	O
CHAPS 	CHAPS 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
filtered  	filtered  	 VBG	O
through  	through  	 IN	O
a  	a  	 DT	O
0.4  	0.4  	 CD	O
micron  	micron  	 CD	O
membrane  	membrane  	 NNS	O
and  	and  	 CC	O
its  	its  	 PRP$	O
soluble  	soluble  	 JJ	B-NP
components  	components  	 NNS	I-NP
subjected  	subjected  	 VBN	O
to  	to  	 TO	O
anion-exchange  	anion-exchange  	 JJ	B-NP
column  	column  	 NN	I-NP
chromatography  	chromatography  	 VBZ	O
using  	using  	 VBG	O
Q-Sepharose  	Q-Sepharose  	 JJ	B-NP
Fast  	Fast  	 NNP	O
Flow  	Flow  	 NNP	O
( 	( 	 -LRB-	O
1  	1  	 CD	O
ml  	ml  	 JJ	B-NP
bed  	bed  	 NN	I-NP
volume 	volume 	 NN	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
column  	column  	 NN	O
was  	was  	 VBD	O
washed  	washed  	 VBN	O
with  	with  	 IN	O
15-column  	15-column  	 CD	O
volumes  	volumes  	 NNS	O
of  	of  	 IN	O
buffer  	buffer  	 JJ	B-NP
Q 	Q 	 NNP	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
bound  	bound  	 JJ	O
material  	material  	 NN	O
eluted  	eluted  	 NN	O
with  	with  	 IN	O
1.2  	1.2  	 CD	O
M  	M  	 NNP	O
NaCl  	NaCl  	 NNP	B-NP
and  	and  	 CC	O
termed  	termed  	 FW	O
CM  	CM  	 FW	O
a 	a 	 FW	O
.  	.  	 .	O
Alternatively 	Alternatively 	 RB	O
,  	,  	 ,	O
a  	a  	 DT	O
DEAE-Sephacel  	DEAE-Sephacel  	 JJ	B-NP
column  	column  	 NN	I-NP
was  	was  	 VBD	O
used 	used 	 VBN	O
.  	.  	 .	O
PEDF-affinity  	PEDF-affinity  	 JJ	B-NP
column  	column  	 NN	I-NP
chromatography  	chromatography  	 NN	I-NP
To  	To  	 TO	O
identify  	identify  	 VB	O
components  	components  	 NNS	O
with  	with  	 IN	O
PEDF-binding  	PEDF-binding  	 JJ	B-NP
affinity 	affinity 	 NN	I-NP
,  	,  	 ,	O
purified  	purified  	 JJ	O
recombinant  	recombinant  	 JJ	B-NP
protein  	protein  	 NN	I-NP
was  	was  	 VBD	O
used  	used  	 VBN	O
to  	to  	 TO	O
prepare  	prepare  	 VB	O
PEDF-affinity  	PEDF-affinity  	 JJ	B-NP
resin  	resin  	 NN	I-NP
with  	with  	 IN	O
3  	3  	 CD	O
M  	M  	 NNP	O
Emphaze™  	Emphaze™  	 NNP	B-NP
Biosupport  	Biosupport  	 NNP	O
Medium  	Medium  	 NNP	O
( 	( 	 -LRB-	O
Pierce  	Pierce  	 NNP	O
Chemical 	Chemical 	 NNP	O
)  	)  	 -RRB-	O
[  	[  	 -LRB-	O
18  	18  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
CM  	CM  	 NNP	O
awas  	awas  	 VBD	O
dialyzed  	dialyzed  	 VBN	O
against  	against  	 IN	O
buffer  	buffer  	 JJ	B-NP
P  	P  	 NN	I-NP
( 	( 	 -LRB-	O
20  	20  	 CD	O
mM  	mM  	 JJ	B-NP
sodium  	sodium  	 NNS	I-NP
phosphate  	phosphate  	 VBP	O
pH  	pH  	 JJ	O
7 	7 	 CD	O
,  	,  	 ,	O
150  	150  	 CD	O
mM  	mM  	 JJ	B-NP
NaCl 	NaCl 	 NN	I-NP
,  	,  	 ,	O
0.5 	0.5 	 CD	O
%  	%  	 NN	O
CHAPS 	CHAPS 	 NNP	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
filtrated  	filtrated  	 NN	O
through  	through  	 IN	O
0.4  	0.4  	 CD	O
μm  	μm  	 CD	B-NP
filters 	filters 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
soluble  	soluble  	 JJ	B-NP
dialysate  	dialysate  	 NN	I-NP
was  	was  	 VBD	O
mixed  	mixed  	 VBN	O
with  	with  	 IN	O
PEDF-resin  	PEDF-resin  	 NNP	B-NP
( 	( 	 -LRB-	O
6  	6  	 CD	O
mg  	mg  	 FW	B-NP
PEDF 	PEDF 	 FW	I-NP
/ 	/ 	 FW	I-NP
ml  	ml  	 FW	I-NP
resin 	resin 	 FW	I-NP
)  	)  	 -RRB-	O
at  	at  	 IN	O
a  	a  	 DT	O
2 	2 	 CD	O
: 	: 	 :	O
1  	1  	 CD	O
volume-to-volume  	volume-to-volume  	 JJ	B-NP
ratio  	ratio  	 NN	I-NP
and  	and  	 CC	O
incubated  	incubated  	 NN	O
at  	at  	 IN	O
4°C  	4°C  	 CD	O
with  	with  	 IN	O
gentle  	gentle  	 JJ	O
rocking  	rocking  	 NN	O
for  	for  	 IN	O
16  	16  	 CD	O
h 	h 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
mixture  	mixture  	 NN	O
was  	was  	 VBD	O
packed  	packed  	 VBN	O
into  	into  	 IN	O
a  	a  	 DT	O
10  	10  	 CD	O
ml  	ml  	 FW	O
Polyprep  	Polyprep  	 FW	B-NP
chromatography  	chromatography  	 FW	I-NP
column  	column  	 FW	I-NP
( 	( 	 -LRB-	O
Bio-Rad 	Bio-Rad 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
washed  	washed  	 VBN	O
with  	with  	 IN	O
10-column  	10-column  	 CD	O
volumes  	volumes  	 NNS	O
of  	of  	 IN	O
buffer  	buffer  	 JJ	B-NP
P.  	P.  	 NNP	I-NP
The  	The  	 DT	O
bound  	bound  	 JJ	O
material  	material  	 NN	O
was  	was  	 VBD	O
eluted  	eluted  	 VBN	O
with  	with  	 IN	O
10-column  	10-column  	 CD	O
volumes  	volumes  	 NNS	O
of  	of  	 IN	O
3  	3  	 CD	O
M  	M  	 NNP	O
NaCl 	NaCl 	 NNP	B-NP
,  	,  	 ,	O
desalted  	desalted  	 VBG	O
with  	with  	 IN	O
20  	20  	 CD	O
mM  	mM  	 JJ	B-NP
Tris-HCl  	Tris-HCl  	 JJ	I-NP
pH  	pH  	 JJ	O
8.0 	8.0 	 NN	O
,  	,  	 ,	O
10 	10 	 CD	O
%  	%  	 NN	O
glycerol 	glycerol 	 NN	B-NP
,  	,  	 ,	O
treated  	treated  	 VBN	O
for  	for  	 IN	O
protein  	protein  	 NN	B-NP
depletion 	depletion 	 NN	I-NP
,  	,  	 ,	O
dialyzed  	dialyzed  	 VBG	O
against  	against  	 IN	O
deionized  	deionized  	 JJ	B-NP
water 	water 	 NN	I-NP
,  	,  	 ,	O
lyophilized  	lyophilized  	 NN	O
and  	and  	 CC	O
resuspended  	resuspended  	 NN	B-NP
in  	in  	 IN	O
deionized  	deionized  	 JJ	B-NP
water 	water 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
final  	final  	 JJ	B-NP
sample  	sample  	 NN	I-NP
was  	was  	 VBD	O
termed  	termed  	 VBN	O
CM  	CM  	 NNP	O
PEDF 	PEDF 	 NNP	B-NP
.  	.  	 .	O
About  	About  	 IN	O
100  	100  	 CD	O
μl  	μl  	 NN	B-NP
of  	of  	 IN	O
CM  	CM  	 NNP	O
PEDFwere  	PEDFwere  	 NNP	B-NP
obtained  	obtained  	 VBD	O
from  	from  	 IN	O
100  	100  	 CD	O
ml  	ml  	 NN	O
of  	of  	 IN	O
CM 	CM 	 NNP	O
.  	.  	 .	O
Alternatively 	Alternatively 	 RB	O
,  	,  	 ,	O
concentrated  	concentrated  	 VBD	O
CM  	CM  	 NNP	O
was  	was  	 VBD	O
used  	used  	 VBN	O
as  	as  	 IN	O
starting  	starting  	 VBG	B-NP
material  	material  	 NN	I-NP
and  	and  	 CC	O
protein  	protein  	 NN	B-NP
depletion  	depletion  	 NN	I-NP
was  	was  	 VBD	O
omitted 	omitted 	 VBN	O
.  	.  	 .	O
Radioligand  	Radioligand  	 FW	B-NP
binding  	binding  	 FW	I-NP
assays  	assays  	 FW	I-NP
PEDF  	PEDF  	 FW	O
binding  	binding  	 FW	O
to  	to  	 TO	O
cell-surface  	cell-surface  	 JJ	B-NP
receptors  	receptors  	 NNS	I-NP
was  	was  	 VBD	O
assayed  	assayed  	 VBN	O
using  	using  	 VBG	O
biologically  	biologically  	 JJ	O
active  	active  	 JJ	O
radioligand  	radioligand  	 JJ	O
125I-PEDF  	125I-PEDF  	 NN	O
and  	and  	 CC	O
Y-79  	Y-79  	 CD	B-NP
cells  	cells  	 NNS	I-NP
[  	[  	 -LRB-	O
18  	18  	 CD	O
]  	]  	 -RRB-	O
by  	by  	 IN	O
a  	a  	 DT	O
widely-used  	widely-used  	 JJ	O
method  	method  	 NN	O
with  	with  	 IN	O
a  	a  	 DT	O
mechanism  	mechanism  	 NN	O
of  	of  	 IN	O
retention  	retention  	 NN	O
of  	of  	 IN	O
receptors  	receptors  	 NNS	B-NP
on  	on  	 IN	O
polyethylenimine-treated  	polyethylenimine-treated  	 JJ	B-NP
glass-fiber  	glass-fiber  	 JJ	I-NP
filters  	filters  	 NNS	I-NP
based  	based  	 VBN	O
mainly  	mainly  	 RB	O
on  	on  	 IN	O
ionic  	ionic  	 JJ	B-NP
interactions  	interactions  	 NNS	I-NP
[  	[  	 -LRB-	O
32  	32  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Polyethylenimine  	Polyethylenimine  	 NNP	B-NP
binds  	binds  	 VBD	O
strongly  	strongly  	 RB	O
to  	to  	 TO	O
glass 	glass 	 NN	O
,  	,  	 ,	O
which  	which  	 WDT	O
is  	is  	 VBZ	O
negatively  	negatively  	 RB	O
charged  	charged  	 VBN	O
and  	and  	 CC	O
integral  	integral  	 JJ	B-NP
membrane  	membrane  	 JJ	I-NP
proteins  	proteins  	 NNS	I-NP
tend  	tend  	 VBP	O
to  	to  	 TO	O
be  	be  	 VB	O
acidic 	acidic 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
resultant  	resultant  	 JJ	O
polycationic  	polycationic  	 JJ	B-NP
polyethylenimine-coated  	polyethylenimine-coated  	 JJ	I-NP
glass  	glass  	 NN	I-NP
can  	can  	 MD	O
retain  	retain  	 VB	O
cell  	cell  	 NN	O
membranes  	membranes  	 VBZ	O
due  	due  	 JJ	O
to  	to  	 TO	O
their  	their  	 PRP$	O
negative  	negative  	 JJ	B-NP
charges 	charges 	 NNS	I-NP
.  	.  	 .	O
Because  	Because  	 IN	O
binding  	binding  	 VBG	O
of  	of  	 IN	O
cell-surface  	cell-surface  	 JJ	B-NP
receptors  	receptors  	 NNS	I-NP
to  	to  	 TO	O
polyethylenimine  	polyethylenimine  	 VB	O
filters  	filters  	 NNS	O
is  	is  	 VBZ	O
rather  	rather  	 RB	O
insensitive  	insensitive  	 VBN	O
to  	to  	 TO	O
ionic  	ionic  	 VB	O
strength 	strength 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
ionic  	ionic  	 JJ	B-NP
phenomenon  	phenomenon  	 NN	I-NP
is  	is  	 VBZ	O
thought  	thought  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
supplemented  	supplemented  	 VBN	O
by  	by  	 IN	O
hydrophobic  	hydrophobic  	 JJ	B-NP
forces  	forces  	 NNS	I-NP
and  	and  	 CC	O
hydrogen  	hydrogen  	 NN	B-NP
binding  	binding  	 NNS	O
[  	[  	 -LRB-	O
32  	32  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
method  	method  	 NN	O
used  	used  	 VBN	O
with  	with  	 IN	O
Y-79  	Y-79  	 CD	B-NP
cells  	cells  	 NNS	I-NP
and  	and  	 CC	O
radiolabeled  	radiolabeled  	 JJ	B-NP
PEDF  	PEDF  	 NNP	I-NP
has  	has  	 VBZ	O
been  	been  	 VBN	O
described  	described  	 VBN	O
before  	before  	 IN	O
in  	in  	 IN	O
detail  	detail  	 NN	O
[  	[  	 -LRB-	O
18  	18  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Briefly 	Briefly 	 RB	O
,  	,  	 ,	O
cells  	cells  	 NNS	O
cultured  	cultured  	 VBP	O
overnight  	overnight  	 RB	O
in  	in  	 IN	O
serum-deprived  	serum-deprived  	 JJ	B-NP
medium  	medium  	 NN	I-NP
at  	at  	 IN	O
37°C  	37°C  	 NNP	O
were  	were  	 VBD	O
transferred  	transferred  	 VBN	O
to  	to  	 TO	O
ice 	ice 	 CD	B-NP
/ 	/ 	 CD	I-NP
water  	water  	 NN	I-NP
bath  	bath  	 NN	I-NP
for  	for  	 IN	O
10  	10  	 CD	O
minutes  	minutes  	 NNS	O
before  	before  	 IN	O
the  	the  	 DT	O
addition  	addition  	 NN	B-NP
of  	of  	 IN	I-NP
ligand 	ligand 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
reaction  	reaction  	 NN	B-NP
mixtures  	mixtures  	 NNS	I-NP
containing  	containing  	 VBG	I-NP
cell  	cell  	 NN	I-NP
suspensions  	suspensions  	 NNS	I-NP
with  	with  	 IN	O
given  	given  	 VBN	O
radioligand  	radioligand  	 JJ	B-NP
concentrations  	concentrations  	 NNS	I-NP
in  	in  	 IN	O
untreated  	untreated  	 NN	O
or  	or  	 CC	O
treated  	treated  	 JJ	O
media  	media  	 NNS	O
were  	were  	 VBD	O
incubated  	incubated  	 VBN	O
at  	at  	 IN	O
4°C  	4°C  	 CD	O
for  	for  	 IN	O
90  	90  	 CD	O
min 	min 	 NN	B-NP
,  	,  	 ,	O
unless  	unless  	 IN	O
indicated 	indicated 	 JJ	O
.  	.  	 .	O
The  	The  	 DT	O
free  	free  	 JJ	O
and  	and  	 CC	O
bound  	bound  	 VBN	O
125I-PEDF  	125I-PEDF  	 NNP	O
were  	were  	 VBD	O
separated  	separated  	 VBN	O
by  	by  	 IN	O
filtration  	filtration  	 NN	O
through  	through  	 IN	O
glass-fiber  	glass-fiber  	 JJ	B-NP
filters  	filters  	 NNS	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
bound  	bound  	 JJ	O
radioactivity  	radioactivity  	 NN	O
was  	was  	 VBD	O
determined  	determined  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
filters  	filters  	 NNS	O
using  	using  	 VBG	O
a  	a  	 DT	O
β-scintillation  	β-scintillation  	 JJ	B-NP
counter  	counter  	 NN	I-NP
( 	( 	 -LRB-	O
Beckman 	Beckman 	 NNP	O
,  	,  	 ,	O
model  	model  	 NN	B-NP
LS  	LS  	 NNP	I-NP
3801 	3801 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Nonspecific  	Nonspecific  	 JJ	B-NP
binding  	binding  	 NN	I-NP
was  	was  	 VBD	O
calculated  	calculated  	 VBN	O
from  	from  	 IN	O
reactions  	reactions  	 NNS	O
with  	with  	 IN	O
a  	a  	 DT	O
molar-excess  	molar-excess  	 JJ	B-NP
of  	of  	 IN	O
unlabeled  	unlabeled  	 JJ	O
ligand  	ligand  	 NNS	B-NP
( 	( 	 -LRB-	O
≥  	≥  	 NNP	O
50-fold 	50-fold 	 NNP	O
)  	)  	 -RRB-	O
over  	over  	 IN	O
radioligand 	radioligand 	 NN	B-NP
.  	.  	 .	O
Complex-formation  	Complex-formation  	 JJ	B-NP
assays  	assays  	 JJ	I-NP
Complex  	Complex  	 JJ	I-NP
formation  	formation  	 NN	I-NP
between  	between  	 IN	O
PEDF  	PEDF  	 NNP	B-NP
and  	and  	 CC	O
CM  	CM  	 NNP	O
components  	components  	 NNS	O
was  	was  	 VBD	O
assayed  	assayed  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
method  	method  	 NN	O
using  	using  	 VBG	O
ultrafiltration  	ultrafiltration  	 NN	B-NP
through  	through  	 IN	O
membranes  	membranes  	 NN	O
of  	of  	 IN	O
100,000  	100,000  	 CD	O
MW  	MW  	 JJ	B-NP
exclusion  	exclusion  	 NN	I-NP
limit  	limit  	 NN	I-NP
[  	[  	 -LRB-	O
14  	14  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Binding  	Binding  	 JJ	B-NP
reactions  	reactions  	 NNS	I-NP
were  	were  	 VBD	O
performed  	performed  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
given  	given  	 VBN	O
concentration  	concentration  	 NN	B-NP
of  	of  	 IN	O
125I-PEDF  	125I-PEDF  	 CD	O
in  	in  	 IN	O
defined  	defined  	 VBN	O
or  	or  	 CC	O
conditioned  	conditioned  	 JJ	O
media 	media 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
incubations  	incubations  	 NN	O
with  	with  	 IN	O
gentle  	gentle  	 JJ	O
rotation  	rotation  	 NN	B-NP
at  	at  	 IN	O
4°C  	4°C  	 CD	O
for  	for  	 IN	O
2  	2  	 CD	O
h 	h 	 NNS	O
.  	.  	 .	O
Free  	Free  	 JJ	O
and  	and  	 CC	O
bound  	bound  	 JJ	O
ligand  	ligand  	 NN	B-NP
were  	were  	 VBD	O
separated  	separated  	 VBN	O
by  	by  	 IN	O
ultrafiltration  	ultrafiltration  	 NN	B-NP
through  	through  	 IN	O
Microcon-100  	Microcon-100  	 NNP	B-NP
( 	( 	 -LRB-	O
Amicon 	Amicon 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
reaction  	reaction  	 NN	B-NP
mixtures  	mixtures  	 NNS	I-NP
were  	were  	 VBD	O
diluted  	diluted  	 VBN	O
40-fold  	40-fold  	 CD	O
with  	with  	 IN	O
cold  	cold  	 JJ	O
20  	20  	 CD	O
mM  	mM  	 JJ	B-NP
sodium  	sodium  	 NNS	I-NP
phosphate  	phosphate  	 VBP	O
pH  	pH  	 JJ	O
6.5 	6.5 	 CD	O
,  	,  	 ,	O
20  	20  	 CD	O
mM  	mM  	 JJ	B-NP
NaCl 	NaCl 	 NN	I-NP
,  	,  	 ,	O
10 	10 	 CD	O
%  	%  	 NN	O
glycerol  	glycerol  	 NNS	B-NP
and  	and  	 CC	O
immediately  	immediately  	 RB	O
ultrafiltrated 	ultrafiltrated 	 JJ	O
,  	,  	 ,	O
repeating  	repeating  	 VBG	O
twice  	twice  	 RB	O
to  	to  	 TO	O
ensure  	ensure  	 VB	O
removal  	removal  	 NN	O
of  	of  	 IN	O
free  	free  	 JJ	O
ligand  	ligand  	 NN	B-NP
from  	from  	 IN	O
the  	the  	 DT	O
complexes 	complexes 	 NNS	O
.  	.  	 .	O
Each  	Each  	 DT	O
Microcon  	Microcon  	 JJ	B-NP
retenate  	retenate  	 JJ	I-NP
cup  	cup  	 NN	I-NP
was  	was  	 VBD	O
transferred  	transferred  	 VBN	O
to  	to  	 TO	O
scintillation  	scintillation  	 VB	B-NP
vials 	vials 	 NNS	I-NP
,  	,  	 ,	O
mixed  	mixed  	 VBN	O
with  	with  	 IN	O
5  	5  	 CD	O
ml  	ml  	 CD	O
BioSafe  	BioSafe  	 JJ	O
II  	II  	 NNP	O
liquid  	liquid  	 JJ	B-NP
scintillation  	scintillation  	 JJ	I-NP
solution  	solution  	 NN	I-NP
( 	( 	 -LRB-	O
Research  	Research  	 NNP	B-NP
Products  	Products  	 NNPS	I-NP
International 	International 	 NNP	O
)  	)  	 -RRB-	O
by  	by  	 IN	O
extensive  	extensive  	 JJ	B-NP
vortexing 	vortexing 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
its  	its  	 PRP$	O
radioactivity  	radioactivity  	 NN	O
determined  	determined  	 VBN	O
using  	using  	 VBG	O
a  	a  	 DT	O
β-scintillation  	β-scintillation  	 JJ	B-NP
counter 	counter 	 NN	I-NP
.  	.  	 .	O
Nonspecific  	Nonspecific  	 JJ	B-NP
binding 	binding 	 NN	I-NP
,  	,  	 ,	O
calculated  	calculated  	 VBN	O
from  	from  	 IN	O
reactions  	reactions  	 NNS	O
with  	with  	 IN	O
an  	an  	 DT	O
excess  	excess  	 NN	O
of  	of  	 IN	O
unlabeled  	unlabeled  	 JJ	O
ligand  	ligand  	 NNS	B-NP
( 	( 	 -LRB-	O
100-fold 	100-fold 	 NNP	O
)  	)  	 -RRB-	O
over  	over  	 IN	O
radioligand 	radioligand 	 NN	B-NP
,  	,  	 ,	O
reached  	reached  	 VBN	O
about  	about  	 IN	O
40 	40 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
total  	total  	 JJ	B-NP
binding 	binding 	 NN	I-NP
.  	.  	 .	O
Enzymatic  	Enzymatic  	 JJ	B-NP
digestion  	digestion  	 JJ	I-NP
treatments  	treatments  	 NNS	I-NP
The  	The  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
GAGs  	GAGs  	 NNP	O
was  	was  	 VBD	O
assayed  	assayed  	 VBN	O
using  	using  	 VBG	O
specific  	specific  	 JJ	O
GAG  	GAG  	 NNP	B-NP
lyases 	lyases 	 NN	I-NP
,  	,  	 ,	O
i.e.  	i.e.  	 FW	O
,  	,  	 ,	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
heparin 	heparin 	 NN	B-NP
,  	,  	 ,	O
HS 	HS 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
chondroitin  	chondroitin  	 JJ	B-NP
sulfates  	sulfates  	 NN	I-NP
with  	with  	 IN	O
heparinase 	heparinase 	 NN	B-NP
,  	,  	 ,	O
heparitinase 	heparitinase 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
chondroitin  	chondroitin  	 JJ	B-NP
ABC  	ABC  	 NNP	I-NP
respectively 	respectively 	 RB	O
.  	.  	 .	O
The  	The  	 DT	O
amount  	amount  	 NN	O
of  	of  	 IN	O
GAGs  	GAGs  	 NNP	O
was  	was  	 VBD	O
determined  	determined  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
amount  	amount  	 NN	O
of  	of  	 IN	O
Δ  	Δ  	 NNP	O
4-hexuronate  	4-hexuronate  	 NNP	O
produced  	produced  	 VBD	O
after  	after  	 IN	O
the  	the  	 DT	O
eliminative  	eliminative  	 JJ	B-NP
cleavage  	cleavage  	 NN	I-NP
of  	of  	 IN	O
each  	each  	 DT	O
substrate  	substrate  	 NN	O
by  	by  	 IN	O
the  	the  	 DT	O
corresponding  	corresponding  	 JJ	O
GAG  	GAG  	 NNP	B-NP
lyase 	lyase 	 NN	I-NP
.  	.  	 .	O
Samples  	Samples  	 NNS	O
were  	were  	 VBD	O
depleted  	depleted  	 VBN	O
of  	of  	 IN	O
proteins  	proteins  	 NNS	O
by  	by  	 IN	O
protease  	protease  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
to  	to  	 TO	O
avoid  	avoid  	 VB	O
interference  	interference  	 NN	B-NP
in  	in  	 IN	O
absorbance  	absorbance  	 JJ	B-NP
readings  	readings  	 NNS	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
product 	product 	 NN	O
.  	.  	 .	O
For  	For  	 IN	O
heparinase  	heparinase  	 NN	B-NP
and  	and  	 CC	O
heparitinase  	heparitinase  	 JJ	B-NP
reactions 	reactions 	 NNS	I-NP
,  	,  	 ,	O
samples  	samples  	 NNS	O
were  	were  	 VBD	O
treated  	treated  	 VBN	O
with  	with  	 IN	O
5  	5  	 CD	O
milliunits  	milliunits  	 NN	B-NP
of  	of  	 IN	O
each  	each  	 DT	O
enzyme  	enzyme  	 NN	B-NP
in  	in  	 IN	O
150  	150  	 CD	O
μl  	μl  	 NN	B-NP
of  	of  	 IN	O
0.1  	0.1  	 CD	O
M  	M  	 NNP	O
sodium  	sodium  	 NN	B-NP
acetate  	acetate  	 NN	I-NP
and  	and  	 CC	O
1  	1  	 CD	O
mM  	mM  	 JJ	O
CaCl  	CaCl  	 JJ	B-NP
2  	2  	 CD	O
,  	,  	 ,	O
pH  	pH  	 JJ	O
7  	7  	 CD	O
and  	and  	 CC	O
incubations  	incubations  	 NN	O
at  	at  	 IN	O
37°C  	37°C  	 CD	O
for  	for  	 IN	O
various  	various  	 JJ	O
time  	time  	 NN	B-NP
periods 	periods 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
reactions  	reactions  	 NNS	O
were  	were  	 VBD	O
stopped  	stopped  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
addition  	addition  	 NN	B-NP
of  	of  	 IN	O
1  	1  	 CD	O
ml  	ml  	 NN	O
of  	of  	 IN	O
0.06  	0.06  	 NNP	O
M  	M  	 NNP	O
HCl 	HCl 	 NNP	B-NP
.  	.  	 .	O
The  	The  	 DT	O
soluble  	soluble  	 JJ	B-NP
material  	material  	 NN	I-NP
was  	was  	 VBD	O
separated  	separated  	 VBN	O
by  	by  	 IN	O
centrifugation  	centrifugation  	 NNS	B-NP
( 	( 	 -LRB-	O
3000  	3000  	 CD	O
×  	×  	 CD	O
g  	g  	 NN	O
,  	,  	 ,	O
10  	10  	 CD	O
min 	min 	 CD	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
assayed  	assayed  	 NN	O
for  	for  	 IN	O
absorbance  	absorbance  	 NN	B-NP
at  	at  	 IN	O
235  	235  	 CD	O
nm  	nm  	 NN	B-NP
to  	to  	 TO	O
measure  	measure  	 VB	O
the  	the  	 DT	O
concentration  	concentration  	 NN	B-NP
of  	of  	 IN	O
product  	product  	 NN	O
Δ  	Δ  	 NNP	O
4-hexuronate  	4-hexuronate  	 NNP	O
( 	( 	 -LRB-	O
Molar  	Molar  	 FW	B-NP
extinction  	extinction  	 FW	I-NP
coefficient  	coefficient  	 FW	I-NP
=  	=  	 SYM	O
5500 	5500 	 CD	O
;  	;  	 :	O
[  	[  	 -LRB-	O
33  	33  	 CD	O
]  	]  	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
For  	For  	 IN	O
the  	the  	 DT	O
chondroitinase  	chondroitinase  	 JJ	B-NP
ABC  	ABC  	 NNP	I-NP
reactions 	reactions 	 NNS	I-NP
,  	,  	 ,	O
each  	each  	 DT	O
chondroitin  	chondroitin  	 JJ	B-NP
sulfates  	sulfates  	 JJ	I-NP
A 	A 	 NN	O
,  	,  	 ,	O
B  	B  	 NNP	O
and  	and  	 CC	O
C  	C  	 $	O
substrate  	substrate  	 CD	O
( 	( 	 -LRB-	O
1  	1  	 CD	O
mg  	mg  	 CD	B-NP
each 	each 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
concentrated  	concentrated  	 JJ	O
CM 	CM 	 NNP	O
,  	,  	 ,	O
were  	were  	 VBD	O
incubated  	incubated  	 VBN	O
with  	with  	 IN	O
0.12  	0.12  	 CD	O
units  	units  	 NNS	O
of  	of  	 IN	O
chondroitinase  	chondroitinase  	 JJ	B-NP
ABC  	ABC  	 NNP	I-NP
in  	in  	 IN	O
1  	1  	 CD	O
ml  	ml  	 NN	O
of  	of  	 IN	O
50  	50  	 CD	O
mM  	mM  	 JJ	B-NP
Tris-HCl  	Tris-HCl  	 JJ	I-NP
pH  	pH  	 JJ	O
8.0 	8.0 	 NN	O
,  	,  	 ,	O
60  	60  	 CD	O
mM  	mM  	 JJ	O
sodium  	sodium  	 JJ	B-NP
acetate 	acetate 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
0.02 	0.02 	 CD	O
%  	%  	 NN	O
BSA  	BSA  	 NN	B-NP
at  	at  	 IN	O
37°C 	37°C 	 CD	O
.  	.  	 .	O
At  	At  	 IN	O
various  	various  	 JJ	O
time  	time  	 NN	B-NP
periods 	periods 	 NNS	I-NP
,  	,  	 ,	O
aliquots  	aliquots  	 VBG	O
of  	of  	 IN	O
0.1  	0.1  	 CD	O
ml  	ml  	 NNS	O
were  	were  	 VBD	O
removed  	removed  	 VBN	O
and  	and  	 CC	O
mixed  	mixed  	 VBN	O
with  	with  	 IN	O
0.9  	0.9  	 CD	O
ml  	ml  	 NN	O
of  	of  	 IN	O
45  	45  	 CD	O
mM  	mM  	 JJ	O
KCl  	KCl  	 JJ	B-NP
pH  	pH  	 JJ	O
1.8  	1.8  	 CD	O
to  	to  	 TO	O
stop  	stop  	 VB	O
the  	the  	 DT	O
reaction 	reaction 	 NN	O
.  	.  	 .	O
Insoluble  	Insoluble  	 JJ	B-NP
material  	material  	 NN	I-NP
was  	was  	 VBD	O
removed  	removed  	 VBN	O
by  	by  	 IN	O
centrifugation  	centrifugation  	 NNS	B-NP
( 	( 	 -LRB-	O
1000  	1000  	 CD	O
×  	×  	 CD	O
g  	g  	 NN	O
,  	,  	 ,	O
10  	10  	 CD	O
min 	min 	 CD	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
the  	the  	 DT	O
supernatant  	supernatant  	 JJ	B-NP
assayed  	assayed  	 NN	I-NP
for  	for  	 IN	I-NP
absorbance  	absorbance  	 NN	I-NP
of  	of  	 IN	O
Δ  	Δ  	 NNP	O
4-hexuronate  	4-hexuronate  	 NNP	O
at  	at  	 IN	O
232  	232  	 CD	O
nm 	nm 	 NNS	B-NP
.  	.  	 .	O
For  	For  	 IN	O
protein  	protein  	 NN	B-NP
depletion 	depletion 	 NN	I-NP
,  	,  	 ,	O
CM  	CM  	 NNP	O
was  	was  	 VBD	O
mixed  	mixed  	 VBN	O
with  	with  	 IN	O
subtilisin  	subtilisin  	 NN	B-NP
at  	at  	 IN	O
0.4  	0.4  	 CD	O
μg 	μg 	 CD	B-NP
/ 	/ 	 CD	I-NP
ml  	ml  	 NN	I-NP
in  	in  	 IN	O
20  	20  	 CD	O
mM  	mM  	 JJ	B-NP
Tris-HCl  	Tris-HCl  	 JJ	I-NP
pH  	pH  	 JJ	O
8.0 	8.0 	 NN	O
,  	,  	 ,	O
10 	10 	 CD	O
%  	%  	 NN	O
glycerol  	glycerol  	 NNS	B-NP
and  	and  	 CC	O
incubated  	incubated  	 NN	O
at  	at  	 IN	O
37°C  	37°C  	 CD	O
for  	for  	 IN	O
16  	16  	 CD	O
h 	h 	 NNS	B-NP
.  	.  	 .	I-NP
Subtilisin  	Subtilisin  	 NNP	I-NP
was  	was  	 VBD	O
heat-inactivated  	heat-inactivated  	 JJ	O
at  	at  	 IN	O
75°C  	75°C  	 CD	O
for  	for  	 IN	O
25  	25  	 CD	O
min 	min 	 NNS	B-NP
.  	.  	 .	O
The  	The  	 DT	O
protein  	protein  	 NN	B-NP
concentration  	concentration  	 NN	I-NP
after  	after  	 IN	O
the  	the  	 DT	O
reaction  	reaction  	 NN	O
was  	was  	 VBD	O
less  	less  	 JJR	O
than  	than  	 IN	O
0.1 	0.1 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
starting  	starting  	 VBG	B-NP
material 	material 	 NN	I-NP
.  	.  	 .	O
To  	To  	 TO	O
deplete  	deplete  	 VB	O
cell  	cell  	 NN	O
cultures  	cultures  	 NNS	O
of  	of  	 IN	O
GAGs 	GAGs 	 NNP	O
,  	,  	 ,	O
Y-79  	Y-79  	 CD	O
cells  	cells  	 NNS	O
in  	in  	 IN	O
defined  	defined  	 VBN	O
serum-free  	serum-free  	 JJ	O
medium  	medium  	 NN	O
( 	( 	 -LRB-	O
as  	as  	 IN	O
above 	above 	 JJ	O
)  	)  	 -RRB-	O
at  	at  	 IN	O
a  	a  	 DT	O
density  	density  	 NN	O
of  	of  	 IN	O
1.25  	1.25  	 CD	O
×  	×  	 CD	O
10  	10  	 CD	O
5cells 	5cells 	 CD	O
/ 	/ 	 CD	O
ml  	ml  	 NNS	O
were  	were  	 VBD	O
cultured  	cultured  	 VBN	O
in  	in  	 IN	O
96-well  	96-well  	 CD	O
culture  	culture  	 NN	O
plates  	plates  	 NNS	O
( 	( 	 -LRB-	O
150  	150  	 CD	O
μl 	μl 	 NNS	O
/ 	/ 	 VBP	O
well 	well 	 RB	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
incubated  	incubated  	 NN	O
at  	at  	 IN	O
37°C  	37°C  	 CD	O
in  	in  	 IN	O
a  	a  	 DT	O
5 	5 	 CD	O
%  	%  	 NN	O
CO  	CO  	 NNP	O
2  	2  	 CD	O
environment  	environment  	 NN	O
for  	for  	 IN	O
16  	16  	 CD	O
h 	h 	 NNS	O
.  	.  	 .	O
Hyaluronidase  	Hyaluronidase  	 NNP	O
( 	( 	 -LRB-	O
> 	> 	 FW	O
1TRU 	1TRU 	 FW	O
/ 	/ 	 FW	O
μl 	μl 	 FW	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
heparinase  	heparinase  	 NNS	O
( 	( 	 -LRB-	O
1  	1  	 CD	O
mu 	mu 	 CD	O
/ 	/ 	 CD	O
μl 	μl 	 CD	O
)  	)  	 -RRB-	O
or  	or  	 CC	O
heparitinase  	heparitinase  	 NNS	O
( 	( 	 -LRB-	O
1  	1  	 CD	O
mu 	mu 	 CD	O
/ 	/ 	 CD	O
μl 	μl 	 CD	O
)  	)  	 -RRB-	O
were  	were  	 VBD	O
each  	each  	 DT	O
added  	added  	 VBN	O
to  	to  	 TO	O
various  	various  	 JJ	O
wells  	wells  	 NNS	O
and  	and  	 CC	O
incubated  	incubated  	 NN	O
at  	at  	 IN	O
37°C  	37°C  	 CD	O
in  	in  	 IN	O
a  	a  	 DT	O
5 	5 	 CD	O
%  	%  	 NN	O
CO  	CO  	 NNP	O
2  	2  	 CD	O
environment  	environment  	 NN	O
for  	for  	 IN	O
1  	1  	 CD	O
h 	h 	 NNS	O
.  	.  	 .	O
Chlorate  	Chlorate  	 JJ	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
cell  	cell  	 NN	O
cultures  	cultures  	 NNS	O
To  	To  	 TO	O
prevent  	prevent  	 VB	O
sulfation  	sulfation  	 VBN	O
of  	of  	 IN	O
GAGs  	GAGs  	 JJ	O
in  	in  	 IN	O
cell  	cell  	 NN	O
cultures 	cultures 	 NNS	O
,  	,  	 ,	O
we  	we  	 PRP	O
used  	used  	 VBD	O
a  	a  	 DT	O
method  	method  	 NN	O
previously  	previously  	 RB	O
described  	described  	 VBN	O
[  	[  	 -LRB-	O
33  	33  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Y-79  	Y-79  	 NNP	O
cells  	cells  	 NNS	O
( 	( 	 -LRB-	O
1.25  	1.25  	 CD	O
×  	×  	 CD	O
10  	10  	 CD	O
5cells 	5cells 	 CD	O
/ 	/ 	 CD	O
ml 	ml 	 CD	O
)  	)  	 -RRB-	O
were  	were  	 VBD	O
cultured  	cultured  	 VBN	O
in  	in  	 IN	O
48-well  	48-well  	 CD	O
plates  	plates  	 NNS	O
( 	( 	 -LRB-	O
300  	300  	 CD	O
μl 	μl 	 NNS	O
/ 	/ 	 VBP	O
well 	well 	 RB	O
)  	)  	 -RRB-	O
in  	in  	 IN	O
defined  	defined  	 VBN	O
serum-free  	serum-free  	 JJ	O
medium  	medium  	 NN	O
with  	with  	 IN	O
or  	or  	 CC	O
without  	without  	 IN	O
30  	30  	 CD	O
mM  	mM  	 JJ	O
sodium  	sodium  	 NN	O
chlorate  	chlorate  	 NNS	O
and  	and  	 CC	O
10  	10  	 CD	O
mM  	mM  	 JJ	O
sodium  	sodium  	 JJ	O
sulfate  	sulfate  	 NN	O
at  	at  	 IN	O
37°C  	37°C  	 CD	O
in  	in  	 IN	O
a  	a  	 DT	O
5 	5 	 CD	O
%  	%  	 NN	O
CO  	CO  	 NNP	O
2  	2  	 CD	O
environment  	environment  	 NN	O
for  	for  	 IN	O
24  	24  	 CD	O
h 	h 	 NNS	O
.  	.  	 .	O
GAG  	GAG  	 NNP	O
detection  	detection  	 FW	O
assays  	assays  	 FW	O
GAGs  	GAGs  	 FW	O
and  	and  	 CC	O
proteins  	proteins  	 NNS	O
resolved  	resolved  	 VBN	O
by  	by  	 IN	O
SDS-polyacrylamide  	SDS-polyacrylamide  	 JJ	B-NP
gel  	gel  	 JJ	I-NP
electrophoresis  	electrophoresis  	 NN	I-NP
in  	in  	 IN	O
Tricine 	Tricine 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
SDS  	SDS  	 NNP	I-NP
buffer 	buffer 	 NN	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
instructed  	instructed  	 VBN	O
by  	by  	 IN	O
manufacturer  	manufacturer  	 NN	B-NP
( 	( 	 -LRB-	O
Novex 	Novex 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
were  	were  	 VBD	O
detected  	detected  	 VBN	O
with  	with  	 IN	O
specific  	specific  	 JJ	O
stains 	stains 	 NNS	O
.  	.  	 .	O
For  	For  	 IN	O
GAG  	GAG  	 NNP	O
detection 	detection 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
gels  	gels  	 NN	O
were  	were  	 VBD	O
incubated  	incubated  	 JJ	O
sequentially  	sequentially  	 NN	O
in  	in  	 IN	O
0.2 	0.2 	 CD	O
%  	%  	 NN	O
Toluidine  	Toluidine  	 NNP	B-NP
Blue-O  	Blue-O  	 NNP	I-NP
in  	in  	 IN	O
ethanol-water-acetic  	ethanol-water-acetic  	 JJ	B-NP
acid  	acid  	 NN	I-NP
( 	( 	 -LRB-	O
50 	50 	 CD	O
: 	: 	 :	O
49 	49 	 CD	O
: 	: 	 :	O
1 	1 	 LS	O
)  	)  	 -RRB-	O
for  	for  	 IN	O
30  	30  	 CD	O
minutes 	minutes 	 NNS	O
,  	,  	 ,	O
in  	in  	 IN	O
ethanol-water-acetic  	ethanol-water-acetic  	 JJ	B-NP
acid  	acid  	 NN	I-NP
( 	( 	 -LRB-	O
50 	50 	 CD	O
: 	: 	 :	O
49 	49 	 CD	O
: 	: 	 :	O
1 	1 	 LS	O
)  	)  	 -RRB-	O
for  	for  	 IN	O
1  	1  	 CD	O
h 	h 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
in  	in  	 IN	O
H  	H  	 NNP	O
2  	2  	 CD	O
O  	O  	 NN	O
for  	for  	 IN	O
16  	16  	 CD	O
h.  	h.  	 CD	O
[  	[  	 -LRB-	O
34  	34  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
For  	For  	 IN	O
protein  	protein  	 NN	B-NP
detection 	detection 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
gels  	gels  	 NN	O
were  	were  	 VBD	O
sequentially  	sequentially  	 JJ	O
incubated  	incubated  	 NN	O
in  	in  	 IN	O
0.5 	0.5 	 CD	O
%  	%  	 NN	O
Coomassie  	Coomassie  	 NNP	B-NP
Brilliant  	Brilliant  	 NNP	I-NP
Blue  	Blue  	 NNP	I-NP
in  	in  	 IN	O
50 	50 	 CD	O
%  	%  	 NN	O
methanol 	methanol 	 VBD	O
/ 	/ 	 CD	O
10 	10 	 CD	O
%  	%  	 NN	O
acetic  	acetic  	 NN	B-NP
acid  	acid  	 NN	I-NP
and  	and  	 CC	O
in  	in  	 IN	O
10 	10 	 CD	O
%  	%  	 NN	O
methanol 	methanol 	 VBD	O
/ 	/ 	 CD	O
10 	10 	 CD	O
%  	%  	 NN	O
isopropanol 	isopropanol 	 NN	B-NP
.  	.  	 .	O
GAG  	GAG  	 NNP	O
detection  	detection  	 NN	O
was  	was  	 VBD	O
also  	also  	 RB	O
performed  	performed  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
Toluidine  	Toluidine  	 JJ	B-NP
Blue-O  	Blue-O  	 JJ	I-NP
precipitation  	precipitation  	 NN	I-NP
and  	and  	 CC	O
dot-blot  	dot-blot  	 JJ	B-NP
method  	method  	 NN	I-NP
as  	as  	 IN	O
described  	described  	 VBN	O
previously  	previously  	 RB	O
[  	[  	 -LRB-	O
34  	34  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Briefly 	Briefly 	 RB	O
,  	,  	 ,	O
200  	200  	 CD	O
μl  	μl  	 NN	B-NP
of  	of  	 IN	O
sample  	sample  	 NN	O
were  	were  	 VBD	O
applied  	applied  	 VBN	O
to  	to  	 TO	O
each  	each  	 DT	O
well  	well  	 RB	O
of  	of  	 IN	O
a  	a  	 DT	O
48-well  	48-well  	 CD	O
manifold  	manifold  	 NNS	O
( 	( 	 -LRB-	O
Life  	Life  	 NNP	O
Technologies 	Technologies 	 NNPS	O
)  	)  	 -RRB-	O
onto  	onto  	 IN	O
a  	a  	 DT	O
PVDF  	PVDF  	 NNP	B-NP
membrane  	membrane  	 NN	I-NP
without  	without  	 IN	O
vacuum 	vacuum 	 NN	B-NP
.  	.  	 .	O
Then 	Then 	 RB	O
,  	,  	 ,	O
5  	5  	 CD	O
μl  	μl  	 NN	B-NP
of  	of  	 IN	O
0.2 	0.2 	 CD	O
%  	%  	 NN	O
Toluidine  	Toluidine  	 NNP	B-NP
blue-O  	blue-O  	 NNP	I-NP
were  	were  	 VBD	O
added  	added  	 VBN	O
to  	to  	 TO	O
each  	each  	 DT	O
well  	well  	 RB	O
and  	and  	 CC	O
vacuum  	vacuum  	 NN	B-NP
was  	was  	 VBD	O
applied 	applied 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
membrane  	membrane  	 NN	O
was  	was  	 VBD	O
removed 	removed 	 VBN	O
,  	,  	 ,	O
washed  	washed  	 VBD	O
twice  	twice  	 RB	O
with  	with  	 IN	O
destaining  	destaining  	 JJ	B-NP
solution  	solution  	 NN	I-NP
( 	( 	 -LRB-	O
ethanol-water-acetic  	ethanol-water-acetic  	 JJ	B-NP
acid 	acid 	 NN	I-NP
,  	,  	 ,	O
50 	50 	 CD	O
: 	: 	 :	O
49 	49 	 CD	O
: 	: 	 :	O
1 	1 	 LS	O
)  	)  	 -RRB-	O
for  	for  	 IN	O
5  	5  	 CD	O
min  	min  	 NNS	B-NP
and  	and  	 CC	O
air-dried 	air-dried 	 JJ	O
.  	.  	 .	O
Other  	Other  	 JJ	O
methods  	methods  	 NNS	O
The  	The  	 DT	O
protein  	protein  	 NN	O
concentration  	concentration  	 NN	O
was  	was  	 VBD	O
determined  	determined  	 VBN	O
using  	using  	 VBG	O
BioRad  	BioRad  	 JJ	O
Protein  	Protein  	 NNP	O
Assay  	Assay  	 NNP	O
( 	( 	 -LRB-	O
BioRad 	BioRad 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Abbreviations  	Abbreviations  	 NNP	B-NP
PEDF 	PEDF 	 NNP	I-NP
,  	,  	 ,	O
pigment  	pigment  	 JJ	B-NP
epithelium-derived  	epithelium-derived  	 JJ	I-NP
factor 	factor 	 NN	I-NP
;  	;  	 :	O
GAG 	GAG 	 NNP	O
,  	,  	 ,	O
glycosaminoglycan 	glycosaminoglycan 	 NNS	B-NP
;  	;  	 :	O
HS 	HS 	 NNP	B-NP
,  	,  	 ,	O
heparan  	heparan  	 JJ	B-NP
sulfate 	sulfate 	 NN	I-NP
;  	;  	 :	O
CM 	CM 	 NNP	O
,  	,  	 ,	O
media  	media  	 NNS	O
conditioned  	conditioned  	 VBN	O
by  	by  	 IN	O
retinoblastoma  	retinoblastoma  	 NN	B-NP
cells 	cells 	 NNS	I-NP
.  	.  	 .	O
Authors 	Authors 	 NNP	O
'  	'  	 POS	O
contributions  	contributions  	 NNS	B-NP
EMA  	EMA  	 NNP	I-NP
participated  	participated  	 VBD	O
in  	in  	 IN	O
the  	the  	 DT	O
design 	design 	 NN	O
,  	,  	 ,	O
assay  	assay  	 JJ	B-NP
development  	development  	 NN	I-NP
and  	and  	 CC	O
carried  	carried  	 VBD	O
out  	out  	 RP	O
the  	the  	 DT	O
complex-formation 	complex-formation 	 JJ	B-NP
,  	,  	 ,	O
GAG  	GAG  	 NNP	O
detection  	detection  	 NN	O
and  	and  	 CC	O
receptor  	receptor  	 JJ	B-NP
binding  	binding  	 JJ	I-NP
assays 	assays 	 NN	I-NP
.  	.  	 .	O
JEW  	JEW  	 NNP	B-NP
carried  	carried  	 VBD	O
out  	out  	 RP	O
the  	the  	 DT	O
purification  	purification  	 NN	B-NP
and  	and  	 CC	O
characterization  	characterization  	 NN	B-NP
of  	of  	 IN	O
GAGs 	GAGs 	 NNP	O
,  	,  	 ,	O
the  	the  	 DT	O
enzymatic  	enzymatic  	 NN	B-NP
and  	and  	 CC	O
chemical  	chemical  	 JJ	B-NP
treatments  	treatments  	 NNS	I-NP
of  	of  	 IN	O
cell  	cell  	 NN	O
cultures  	cultures  	 NNS	O
for  	for  	 IN	O
receptor  	receptor  	 JJ	B-NP
binding  	binding  	 JJ	I-NP
studies 	studies 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
drafted  	drafted  	 VBD	O
the  	the  	 DT	O
manuscript 	manuscript 	 NN	O
.  	.  	 .	O
SPB  	SPB  	 NNP	B-NP
conceived  	conceived  	 VBD	O
the  	the  	 DT	O
study 	study 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
participated  	participated  	 VBD	O
in  	in  	 IN	O
its  	its  	 PRP$	O
design  	design  	 NN	O
and  	and  	 CC	O
coordination 	coordination 	 NN	B-NP
.  	.  	 .	O
All  	All  	 DT	O
authors  	authors  	 NNS	O
read  	read  	 VBP	O
and  	and  	 CC	O
approved  	approved  	 VBD	O
the  	the  	 DT	O
final  	final  	 JJ	B-NP
manuscript 	manuscript 	 NN	I-NP
.  	.  	 .	O
